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Abstract: 
 
The main topic of the article is to observe the current regulatory policy of cannabis and 
the reasons why it should be reorganized so that the society could gain largest potential 
economic benefit. The author basically wanted to prove the need for changes in 
international cannabis regulation. In order to gain the best results, the author uses legal 
and comparative analysis research methods and as credible sources exploits mainly drug 
reports published by international organizations, scientific journal and official 
government data. 
The main findings are that the current international legislation regarding 
cannabis is outdated, ineffective and actually obstructs the society from researching the 
respective substance and its possible advantages. More liberal and at the same time 
more specific regulation of cannabis market is found to be more effective to defeat the 
black market and give benefit to society’s overall well-being. In the conclusion the 
author recommends to change the international cannabis legislation by presenting 
several step control mechanisms of the respective substance.  
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INTRODUCTION 
The outdated international cannabis legal framework has to be modernized, because by 
changing the attitude towards it, we will discover cannabis real nature and potential 
economic benefits. 
This article will prove that the existing international drug law regarding cannabis 
is unrighteous and has to be changed in order to utilize and research potential of the 
respective substance and its possible public and economic benefits. In this work the 
author will mainly focus on, firstly, international cannabis regulation - how it works in 
the real life and what is the situation in the countries, where the domestic cannabis law 
is in discrepancy with the international legislation. Secondly, the author will analyze the 
economic and other benefits related to cannabis policy in the countries, where the 
respective substance is liberated or even legalized.  
The first part will contain observation of the existing international drug 
framework, which regulates cannabis and it related substances. Meaning “cannabis and 
it related substances” includes: 
 Cannabis (marijuana or marihuana) - blooming parts of the cannabis plant, 
excluding the seeds and leaves; 
 Cannabis Plant - any plant of the genus Cannabis; 
 Cannabis Resin (known as “hashish”) - separated resin obtained from the 
cannabis plant; 
 Cannabinoids - different chemical ingredients of cannabis, the most significant - 
THC;  
 THC (dronabinol or Delta-9-tetrahydrocannabinol) - the main psychoactive 
component of cannabis. The designation dronabinol is more commonly used in 
the U.S. and THC - in the Europe1.  
For purposes of clarity the author will mostly use word “cannabis”, which is 
originated from the Latin language and is used in many official international legal 
documents. However, the article will also contain wording “marijuana or marihuana”, 
which is utilized in many domestic law documents.  
The first part of the work will mostly discover the history of how the legal 
framework was created, what were the main substantiations, how does the outline 
works and what contradictions does it consist. Moreover, the author will expose the 
loopholes and drawbacks of the international cannabis legislation, will give possible 
solutions to them and create step-by-step model of changing the legislation.  
In the second part the author will collate three different jurisdictions with more 
liberal attitude towards cannabis. The comparison will include analysis of the differences 
between their cannabis policies, the social outcomes and economic gains. In the 
                                           
1  Definit ions provided by the Drug Enforcement Administration and the Single 
Convention on Narcotic Drugs, 1961.  
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economic part the author will look at the cannabis taxation structure, the respective 
state’s revenues and the different approaches how the three jurisdictions are exploiting 
the funds.  
The first part of the analysis focuses on the Netherlands. Since the respective 
country is known for its tolerant cannabis policy it is, however, in the same time a 
member of the European community, which officially is strictly against the cannabis 
legalization2. As the second and third jurisdiction to be analyzed, the author has chosen 
the U.S. states of Colorado and Washington. Both states were the first jurisdictions in 
the world to legalize cannabis without taking much into account that at the federal level 
the U.S. policy still stands rigorously against the cannabis legalization. In this part of the 
work, the focus will be set on the diverse legislative approaches and the respective 
outcomes that will be observed taking into consideration the statistical data before and 
after the legalization of the respective substance. 
Overall, in this article the author will use legal and comparative analysis research 
methods in order to obtain the most comprehensive insight into the legal regulatory 
system and to gain the most precise data of the real life situation. As credible sources, 
the author will mainly use drug reports published by different international 
organizations, articles from scientific journals and other material prepared by several 
national governments and their institutions.  
  
                                           
2  EMCDDA. A cannabis reader: global issues and local experiences. “Cannabis 
Control in Europe”, 2008, pp. 98-99. Available on: 
http://www.emcdda.europa.eu/system/files/publications/497/emcdda -cannabis-
mon-vol1-web_103716.pdf. Accessed in June 7, 2017. 
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I INTERNATIONAL UNITED NATIONS DRUG CONVENTIONS 
At present there are three United Nations Treaties outlining the international legal 
framework of the drug control - UN Single Convention on Narcotic Drugs, 1961 3 , 
amended by the Protocol in 1972; the UN Convention on Psychotropic Substances, 
1971 4 , and the Convention against Illicit Traffic in Narcotic Drugs and Psychotropic 
Substances, 19885. The listing of the classified substances was created and approved by 
the International Narcotics Control Board (INCB) and Commission on Narcotic Drugs of 
the Council (CND), in accordance with the recommendations of the World Health 
Organization (WHO)6. The aim of this comprehensive international legal approach is to 
control drug abuse at international level and build UN-based drug administration7.  
1.1 UN Single Convention on Drugs, 1961, amended by the 
Protocol in 1972 
United Nations Single Convention on Drugs, 1961 (Single Convention) was the first 
comprehensive legal framework, which consolidated previously drafted drug control 
treaties between 1912 and 1953 8 . The Convention targets systematic control and 
prohibition of the production, manufacture, export, import, distribution and trade of the 
narcotic drugs and limits their use exclusively to medical and scientific purposes9. The 
Single Convention contains four schedules of controlled drugs and has developed 
mechanism how to include new substances into the schedules without fundamentally 
changing the Convention. Consequently, the substances have to be regulated and 
controlled accordingly to the schedule within they are embodied10. 
                                           
3  United Nations Single Convention on Narcotic Drugs, 1961. Available on 
https://www.unodc.org/pdf/convention_1961_en.pdf . Accessed March 21, 2016. 
4  United Nations Convention on Psychotropic Substances, 1971. Available on 
https://www.unodc.org/pdf/convention_1971_en.pdf . Accessed in March 24, 2016. 
In total, 34 States have signed and 183 parties have ratified the Convention of 
1971. 
5  UN Convention against Illicit Traffic in Narcotic Drugs and Psychotropic 
Substances, 1988. Available on: 
https://www.unodc.org/pdf/convention_1988_en.pdf . Accessed in March 24, 2016.  
6 Supra note 3, Art. 3.  
7  Jay Sinha, Government Division of Parliament of Canada, “The history and 
development of the leading international drug control conventions " (prepared for 
the Senate Special Committee on Illegal Drugs, published in February 21, 2001. 
Available on http://www.parl.gc.ca/content/sen/committee/371/ille/library/history -
e.htm. Accessed in March 21, 2016.  
8 Supra note 3, Art. 44 “Termination of previous international treaties”. The Single 
Convention was originally signed by representatives from 54 countries and now it is 
ratified by 125 states.  
9 Supra note 3, Art. 4(c) “General Obligations”.  
10  Transnational Insitute, M. Jelsma, A. Armenta, “The UN Drug Control 
Conventions: a primer”, published in October 2015. Available on 
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Cannabis and cannabis resin have been placed both in Schedule I and IV, 
meaning that it is considered to be particularly dangerous substance with high risk of 
abuse and without any significant therapeutic value11. The Single Convention sets a 
comprehensive regulatory and prohibition framework on how the respective substances 
should be controlled. First, cannabis shall only be used and cultivated for medical and 
scientific purposes12. Manufacturing of it is only permitted under license, which has to be 
issued by the State, or carried out by a State enterprise13. Secondly, the countries are 
requested to prohibit the possession of cannabis and any other mixtures containing the 
respective substance14. The trade and distribution is only allowed under State’s license 
or if carried out by a State enterprise. In a case of any transaction related to the 
regulated substance, the State must control and verify the license and the specifics of 
the particular transaction15. In a case of illicit trafficking the Parties of the Convention 
are required to cooperate with each other and carry out coordinated preventative and 
repressive actions16. Moreover, there are specific provisions regarding the control of 
cannabis defined in the Article 28 of the Single Convention. This article emphasizes the 
need to prevent the misuse and illicit trafficking of cannabis, its leaves and plants17. The 
Single Convention also includes comprehensive penal provisions and requires that 
Each Part shall adopt such measures as will ensure the cultivation, production, 
manufacture, extraction, preparation, possession, offering, offering for sale, 
distribution, purchase, sale, delivery on any terms whatsoever, brokerage, 
dispatch, dispatch in transit, transport, importation and exportation of drugs 
contrary to the provisions of this Convention, and any other action which is the 
opinion of such Party may be contrary to the provisions of this Convention, shall 
be punishable offences when committed intentionally, and that serious offences 
shall be liable to adequate punishment particularly by imprisonment or other 
penalties of deprivation of liberty18. 
However, paragraph 4 of the same Article 36 states that principles how the State 
chooses to penalize the offences shall “be defined, prosecuted and punished in 
conformity with the domestic law of a Party”19. In other words, the Single Convention 
gives Parties discretion and allows domestic interpretation of the respective legal 
requirements. The main reason for this relatively flexible approach is that the 
Convention is not self-executing and the Parties themselves have to implement the 
Convention into their law system. Typical example is the Article 49 “Transitional 
Reservation”, which gives Parties opportunity to reserve the rights to implementation 
                                                                                                                             
https://www.tni.org/fi les/publication-
downloads/primer_unconventions_24102015.pdf . Accessed in March 21, 2016.  
11 Supra note 3, Art. 3, paragraph 5.  
12 Supra note 3, Art. 22 “Special provision applicable to Cultivation”.  
13 Supra note 3, Art. 29.  
14 Supra note 3, Art. 33 “Possession of Drugs”.  
15 3, Art. 30 “Trade and Distribution”.  
16 Supra note 3, Art. 35 “Action Against the Ill icit Traffic”.  
17 Supra note 3, Art. 28 “Control of Cannabis”.  
18 Supra note 3, Art. 36 “Penal Provisions”.  
19 Ibid, para. 4.  
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restrictions regarding opium, coca leaf and cannabis. However, these reservation rights 
are only temporary - the medical and scientific use of cannabis must be suspended ”in 
any case within twenty-five years from the coming into force of this Convention”20. 
Other examples for domestic interpretation can be found in Article 26, paragraph 2 “the 
Parties shall as far as possible” and in Article 30, paragraph 4 “If a Party considers such 
measures necessary or desirable”21.  
Another important field, which is covered by the Convention, is the preventative 
measures to hinder the abuse of drugs. The Article 38 states that Parties have to pay 
special attention to “early identification, treatment, education, after-care, rehabilitation 
and social reintegration of the persons involved”22.   
Overall, the Single Convention, on the one hand, requires Member States to 
prohibit most of the activities related to cannabis. On the other hand, in order to keep 
this Convention attractive to the countries, it gives relative domestic freedom on how 
and when the requirements shall be adopted. As we will see in the following parts of this 
work, in the real life there are several Member States that do not fully respect this 
convention and have actually very different domestic drug policy. In these cases the UN 
is observed to be powerless and is not able to force the countries to act accordingly to 
the Convention. 
1.2 UN Convention on Psychotropic Substances, 1971 
The main reason for the creation of the Convention on Psychotropic Substances was to 
introduce better control mechanism of the diversified drugs that became popular in 
1960s. Convention of 1971 combined with the Single Convention created comprehensive 
and relatively strict legal framework of drug regulation, although, the latest Convention 
in comparison with the Single Convention is considered to be less rigid (except Schedule 
I 23 ). In the Convention on Psychotropic Substances drugs are divided into four 
Schedules, similarly as it is done in the Single Convention. 
Dronabinol (delta-9-tetrahydrocannabinol or THC), which is the main active 
ingredient of cannabis, is included in the Schedule II - substances with some therapeutic 
value. The substances from Schedule II require license or authorized person to be 
manufactured or distributed (including import/export)24. In addition, export and import 
of substances from Schedules I and II require a special authorization, which is created 
and approved by the CND 25 . Moreover, the Convention requires manufacturers and 
authorized people to keep record of traded and distributed substances from Schedules II 
and III26. The penal provisions and actions against the illicit traffic are stated in the 
                                           
20 Supra note 3, Art. 49 “”Transit ional Reservations”.  
21 Supra note 3, Art. 26, paragraph 2 and Art. 30, paragraph 4.  
22 Supra note 3, Art. 38 “Measure Against the Abuse of Drugs”.  
23 Supra note 10.  
24 Supra note 4, Art. 8 “Licenses”.  
25 Supra note 4, Art. 12 “Provisions Relating to International Trade”.  
26 Supra note 4, Art, 11 “Records”.  
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Articles 21 and 22 and, according to them, the States are required to cooperate with 
each other and fight against the illicit traffic27. In any case of intentional offence or any 
action against the Convention, the State shall apply adequate punishment, which is in 
conformity with the domestic law28.  
From the very beginning the placement of dronabinol has been a controversial 
issue. At the time when the Convention on Psychotropic Substances was adapted 
dronabinol was placed in the Schedule I as a particularly harmful substance to the 
human health. In 1987 the CND at its twenty-sixth meeting rejected the WHO proposal 
to reschedule dronabinol to Schedule II. However, in 1991 on the grounds that 
dronabinol possesses low risk of abuse and has a therapeutic value dealing with weight 
loss of AIDS patients, nausea and vomiting of the cancer chemotherapy patients, the 
CND did follow the WHO recommendation and replaced dronabinol to the Schedule II29. 
In 2002 the WHO published “Critical review”30, in which they suggested that dronabinol 
should be reclassified to Schedule IV because of its little harm to the public health and 
potential therapeutic value. This proposal, however, was rejected. In 2006 the WHO 
repeatedly recommended to reschedule the dronabinol and its stereoisomers, this time 
to Schedule III of the 1971 Convention 31 . At the meeting of the CND in 2007 the 
members agreed to postpone the decision due to the political pressure and argument 
that dronabinol needs to be researched more extensively. In 2014 meeting of the CND 
the WHO once again, based on the previous recommendation from 2006, proposed to 
replace dronabinol to Schedule III. With 9 votes in favor, 20 against and 12 votes 
absent, the proposal was rejected. However, the WHO still holds the position in favor of 
dronabinol replacement to Schedule III32.  
1.3 UN Convention against Illicit Traffic in Narcotic Drugs and 
Psychotropic Substances, 1988 
This particular convention was created to combat expanding transnational organized 
crime. It specially focuses on international cooperation between the 189 Member States 
and creates a comprehensive approach how to enforce the Single Convention and 
Convention on Psychotropic Substances. The Member States are required to establish 
                                           
27 Supra note 4, Art. 21 “Action against the Ill icit Trafic”.  
28 Supra note 4, Art. 22 “Penal Provisions”.  
29 ECDD, 34 th report 2006/4.2. Assessment of dronabinol and its stereo-isomers, p. 
1. Available on: 
http://www.who.int/medicines/areas/quality_safety/4.2DronabinolCritReview.pdf . 
Accessed in March 24, 2016.  
30 WHO. Technical Report Series, thirty -sixth report. WHO Expert Committee on 
Drug Dependence, p. 4. Available on: 
http://apps.who.int/medicinedocs/documents/s21771en/s21771en.pdf . Accessed in 
March 24, 2016. 
31 Ibid.  
32 Supra note 30.  
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criminal law offences for any activities, where substances from Single Convention and 
Convention on Psychotropic Substances are involved33.  
The Convention of 1988 focuses mainly on manufacturing, distribution, 
possession and international sale (import, export)34 and presents several methods how 
the Member States should punish the actions that are in conflict with the Conventions. 
First, the State of jurisdiction “shall take measures to identify, trace, freeze or seize 
property, instruments” 35  if an unlawful action regarding drugs and/or psychotropic 
substances has taken place. Article 6 focuses on extradition and encourages parties to 
cooperate and carry out multilateral agreements to successfully fulfill the criteria of the 
Convention36.   
The drug possession for personal use is criminally punishable under Article 3, 
paragraph 2 of the Convention, 1988: 
Subject to its constitutional principles and the basic concepts of its legal system, 
each Party shall adopt such measures as may be necessary to establish a 
criminal offences under its domestic law, when committed internationally, the 
possession, purchase or cultivation of narcotic drugs of psychotropic substances 
for personal consumption contrary to the provisions of the 1961 Convention, the 
1961 Convention as amended or the 1971 Convention37.  
Cannabis is especially distinguished in the 1988 Convention, which requests the Member 
States to create criminal offences under national law when dealing with the cultivation of 
“cannabis plant for the purpose of the production of narcotic drugs”38. Another provision 
of the 1988 Convention that tackles cannabis restrictions is the prevention of the illicit 
cultivation of cannabis plants39.  
1.4 Drawbacks of the existing cannabis regulations 
When the first legal regulations on cannabis came into force, they were aimed to 
prohibit the production, distribution and use of it and sanction all transactions thought a 
punishing mechanism. It was believed that the use of illicit drugs would be reduced or 
even eliminated in fear of harsh punishments. The two-tier system, on the one hand, 
attempted to limit the supply of cannabis (and other illegal substances) through the 
regulation of production and distribution and, on the other hand, strived to eliminate the 
demand for cannabis through punishing mechanism. Since the creation of the 
Conventions in 1961, 1971 and 1988 there have not been much of changes in the legal 
framework. However, the present situation shows that in the real life the existing law 
                                           
33 International Drug Policy Consortium. Drug Policy Guide. Edition 2, March 2012, 
pp. 17-24. Available on: http://www.drugpolicy.org/sites/default/fi le s/IDPC-Drug-
Policy-Guide_2nd-Edition.pdf. Accessed in March 24, 2016.  
34 Supra note 5, Art. 3, para. 1a(i).  
35 Supra note 5, Art. 5, para. 4b.  
36 Supra note 5, Art. 6, para. 11.  
37 Supra note 5, Art. 3, para. 2.  
38 Supra note 5, Art. 3, para. 1a(ii).  
39 Supra note 5, Art. 14, para. 2.  
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outlines are not effective enough to combat the illicit cannabis transactions and its wide 
prevalence.  
1.4.1 Wide prevalence of cannabis 
Cannabis is the most widely used drug in the world with 181.8 million of global users40. 
However, the actual worldwide prevalence is difficult to measure, because it varies from 
one-time to permanent users and differs from continent to continent. The data from 
World Drug Report 2016 reveals that in Americas cannabis is the most popular illicit 
substance with 8.4% users of the population 41 . Moreover, 64% of the worldwide 
cannabis seizures were conducted in the U.S. and Mexico42. The recent data also shows 
increase in cannabis use in South America, especially in Chile and Columbia with 
respectively 7.5% and 3.3% of the previous year 43 . In Asia, however, cannabis 
consumption is still below the average world consumption and reaches 1.9% of the 
population aged 15-6444. In Oceania and Africa prevalence of cannabis is estimated as 
wide. Due to its historical and cultural roots, the level of cannabis users in Oceania 
reaches approx. 10.7%45. Similarly, also Africa tends to have high level of cannabis 
consumption. Although there is limited data available, the approximate estimates 
indicate 7.5% of cannabis users among the population aged 15-6446. Even though the 
European cannabis market is one of the largest in the world, the prevalence of cannabis 
use in recent years has remained stable or even slightly decreased47. The EMCDDA Drug 
Report 2016 estimates that approximately 80 million adult Europeans have consumed 
cannabis at least once in their lifetime and over 22 million have done it in the previous 
year48. Moreover, cannabis with 38% share is the most commonly sold illicit drug in the 
EU and approximately 1% of EU population uses it daily49.  
The EU market is mostly supplied with locally cultivated cannabis. Nevertheless, 
the cannabis resin (hashish) is mostly imported from Morocco. In addition, the recent 
years show tendency that the imported hashish contains higher THC level, which, in 
                                           
40 United Nations Office on Drugs and Crime. World Drug Report 2015, Chapter I, p. 
57. Available on: 
https://www.unodc.org/documents/wdr2015/World_Drug_Report_2015.pdf. 
Accessed in March 25, 2016.  
41 United Nations Office on Drugs and Crime. World Drug Report 2014, Chapter 1, 
p. 40. Available on: 
https://www.unodc.org/documents/wdr2014/World_Drug_Report_2014_web.pdf . 
Accessed in March 25, 2016.  
42 Ibid, p. 59. 
43 Supra note 41, p. 59.  
44 Supra note 41, p. 61.  
45 Ibid.  
46 Supra note 41, p. 62.  
47 Supra note 41, p. 60.  
48 EMCDDA. EU Drug Markets Report 2016: In-Depth Analysis, p. 58. Available on: 
http://www.emcdda.europa.eu/system/files/publications/2373/TD0216072ENN.PDF . 
Accessed in March 26, 2016.  
49 Ibid, p. 11.  
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other words, means that the imported substances become more harmful to the users. 
The increase of THC can be explained differently. On the one hand, the cultivation 
techniques have developed significantly and there are available higher-potency cannabis 
strains. On the other hand, even though officially cannabis is among the illegal drugs in 
Europe, the intensity of its production is increased sharply due to the growing demand50.  
Overall, the UN Drug reports show an annual increase of the worldwide use of 
cannabis. This trend evidently shows that the existing legal policy against the cannabis 
use, illicit production, distribution and trafficking is failing. This failure can be largely 
associated with the internationally unbalanced regulation of the production and 
consumption of the respective substance. Although internationally cannabis is strictly 
prohibited, many countries in their national law systems de facto recognize it as less 
harmful substance and apply much more tolerant policies (Appendix 1). This 
disharmonized and disproportionate law regime leads to consequences that cannabis is 
the most widespread illicit drug it the world.   
1.4.2 Incommensurate regulation  
The international drug control framework and each country’s national legislation 
schedule substances according to their actual and potential harm caused both to the 
users themselves and the society. The substances included in schedules are subject to 
corresponding restrictive measures, prohibitions and penalties that punish offences 
related to the respective drugs. The question is, however, whether this principle has 
been applied to all substances adequately, taking into account all the qualities that the 
respective substance possesses.  
The Single Convention was created 50 years ago when the scientific evidence 
and proof of many substances was not complete. One of the most often disputed issues 
is cannabis placement in the strictest groups of substances - Schedule I and IV. Since 
the foundation of the Single Convention the WHO has several times recommended 
rescheduling of cannabis based on the recent evidence of its therapeutic value against 
“spasticity, chronic pain and some neuropsychiatric symptoms” 51 . Recently several 
research projects in the U.S. have shown cannabis THC potential in killing cancer cells. 
Laboratory experiments on rats reveal that cannabinoids kill cancer cells while protecting 
normal cells. It also shows that THC may reduce the risk of colon, breast and liver 
cancers52. Moreover, recently researchers have found that physical harm and risk of 
                                           
50 Supra note 48, p. 57.  
51 ECDD, 36th agenda item 8.2, 2014, p. 8. Available on: 
http://www.who.int/medicines/areas/quality_safety/8_2_Cannabis.pdf . Accessed in 
March 30, 2016.  
52 The Telegraph, US government says cannabis kil ls cancer cells, August 24, 2015. 
Available on: 
http://www.telegraph.co.uk/news/worldnews/northamerica/usa/11820620/US-
government-says-cannabis-kills-cancer-cells.html. Accessed in April 1, 2016.  
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dependence on cannabis is less likely to happen, in comparison with such legal 
substances as tobacco and alcohol (Image 1).  
 
 
Image 1. Source:” The Lancet” 369 (2007).53 
In addition, the US National Institute of Health analyzed the probability of developing 
dependence among nicotine, alcohol, cannabis and cocaine users. To gather data the 
Institute used National Epidemiological Survey on Alcohol and Related Conditions 
(NESARC). The results showed that the accumulated estimate of potential transition to 
dependence for nicotine users was 67.5%, for alcohol users 22.7% and for cannabis 
                                           
53 Daniel Kroll, “Obama’s right: Marijuana is far safer than alcohol, but not entirely 
risk-free”, Forbes Online, February 1, 2014. Available on 
http://www.forbes.com/sites/davidkroll/2014/02/01/obamas-right-marijuana-is-far-
safer-than-alcohol-but-not-entirely-safe/#1f20d39e1400. Accessed in March 30, 
2016.  
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users 8.9%54. This research gives another proof that cannabis is the least harmful from 
the three most frequently used recreational substances.  
Another research carried out in the UK by scientist David Nutt and published in 
the Lancet journal55 shows that cannabis causes much less harm both to users and to 
other than, for instance, alcohol and tobacco (Image 2). 
Image 2. Source: D. Nutt, “Drug harms in the UK”, Lancet, 2010. 
                                           
54 US National Institutes of Health; C. Lopez-Quintero, J.P. De los Cobos, D.S. Hain, 
M. Okuda, S. Wang, B.F. Grant, C. Blanco . “Probability and predictors of transition 
form first use to dependence on nicotine, alcohol, cannabis and cocaine: Results of 
the NESARC, 2012”. Available on: 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069146/  Accessed in March 30, 
2016.  
55 “Drug harms in the UK: a multicriteria decision analysis ”. Lancet, 376 (2010): pp. 
1558-1565. Available on: http://www.thelancet.com/pdfs/journals/lancet /PIIS0140-
6736(10)61462-6.pdf  Accessed in June 7, 2017. 
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The research was carried out based on two-stage mechanism. First was the choice of 
harm criteria, which were recommended by the UK advisory council of the Misuse of 
Drugs (ACMD). It suggested to distinguished 16 potential harm areas, 9 related to self-
harm and 7 associated with harm to the society (Appendix 2).  Second stage was to 
create Independent Scientific Committee on Drugs (ISCD), which consisted of experts 
and external experts and developed the MCDA model with purpose to assess the scores 
for 20 most widespread drugs in the UK. The expert groups then assessed, openly 
discussed and scored each drug based both on its harm to users and to the society. In 
order to ensure that the weighted scores are unprejudiced and could be crosschecked 
and combined with each other the researchers applied concept of swing weighting. So, 
for instance, the evaluation criterion “drug related mortality” was judged as most serious 
aspect and was given a weight of 100.  
The most harmful substances to society were revealed to be alcohol (46% out of 
100%=max), heroin with 21% and crack cocaine with 17%. The most harmful drugs to 
the users are crack cocaine (37%), heroin (34%) and methamphetamine (32%). In 
overall comparison alcohol scores the largest amount of points with 72%, heroin with 
55% and crack cocaine with 54%. If we compare the three most used substances 
worldwide - alcohol, tobacco and cannabis, the lowest score received cannabis (20%), in 
comparison, tobacco scored 26% out of 100%.  
Another important research that specially triggers the issue of existing 
disproportionate scheduling of cannabis was also published by The Lancet journal56 and 
its researcher group lead by Nutt, only earlier - in 2007 (Table 1). This research 
evaluates the discrepancy between the levels of different drug control strictness and 
levels of existing (and potential) harm presented by the respective substances. In the 
Table 1 the substances were classified in four groups based on the UN classification - 
most dangerous, moderate risk, low risk and not subject to international control. 
The most dangerous and under strictest control were revealed to be heroin and 
cocaine. Alcohol, however, was also considered as one of the harmful substances, yet it 
is not subject to the UN regulations or any other international drug related legal 
frameworks. Moreover, tobacco also scored higher result and was recognized as more 
health-harmful substance than cannabis. The latest is placed in the 10th place from 17 
analyzed substances but is still regulated more strictly than any other of the substances 
above.  
                                           
56 D. Nutt, LA King, W. Saulsbury, C. Blakemore, “Development of a rational scale 
to assess the harm of potential misuse”. Lancet, 369 (2007): pp. 1047-1057. 
Accessed in April 1, 2016.   
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Table 1. Source: War on Drugs, Report of the Global Commission on Drug Policy, 2011. 
1.4.3 International cannabis control framework inconsistency with the human 
rights 
The international drug control framework (the three Conventions) embodies many 
restrictive measures that aim to limit production, sale, distribution (trafficking) and use 
of cannabis and it consisting substances. There have been discussions whether the 
benefit of such regulations is more valuable that the restriction of several important 
aspects of human rights. One the one hand, the intended result of the Conventions is to 
protect society health and well-being but, on the other hand, the outline of the existing 
regulatory mechanism is violating several human rights basic principles.  
As it is mentioned above, the Convention-system’s main target is to improve the 
society health, welfare and protect it from the violence and organized crime related 
actions. Nevertheless, in order to ensure that all the legislative outlines are in 
conformity, we have to take into consideration not only prohibiting and restrictive 
regulations regarding specific substances but also rights and obligations that countries 
and international organizations owe to the public. One of the main international 
documents that provide such standards of individual rights is the Universal Declaration 
of Human Rights. The Article 25, paragraph 1 of the Human Rights Declaration obviously 
emphasizes that “Everyone has right to (…) medical care”57. In this regard, several 
researches carried out in the past decade show that cannabis has a therapeutic value 
dealing with pain relief of HIV/AIDS, Diabetic neuropathy, Alzheimer’s disease, cancer 
                                           
57  Universal Declaration of Human Rights, Art. 25, para. 1. Available on: 
http://www.ohchr.org/EN/UDHR/Documents/UDHR_Translations/eng.pdf . Accessed 
in March 29, 2016. 
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chemotherapy- induced nausea and vomiting 58 . In other words, researches prove 
cannabis medical effects and their use in several medical treatments. Basically, Articles 
25 and 12 require countries to provide patients with the possibility to use different 
treatment methods, which, in some cases, include cannabis.     
 Another important aspect regarding cannabis is its cultivation and production. 
Historically people in many countries (especially in Africa and South America) have 
grown and used cannabis for medical purposes. However, with the international 
prohibition regarding the respective substance these people have become undesirable 
and their occupation - illegal. In Article 22 and 23 of the Universal Declaration of Human 
Rights it is stated that every member of the society has rights to work, choose his/her 
own field of employment and, accordingly, develop work skills59. In this context the 
author agrees with the International Drug Policy Consortium report (see footnote 33) 
and its researchers that by prohibiting the cultivation of cannabis (especially in places 
where it has been done for centuries) the human rights are being violated, the potential 
of economic and employment system is not fulfilled and the argument to protect the 
social well-being is actually failing60.  
Moreover, another important field affected by the prohibiting Conventions is the 
individual rights to privacy. The Universal Declaration of Human Rights, Article 12 states 
that  
No one shall be subjected to arbitrary interference with his privacy, family, home 
or correspondence, nor to attacks upon his honor and reputation. Everyone has 
the right to the protection of the law against such interference or attacks.61 
The Single Convention, however, authorizes the Member States to “use measures as 
may be necessary to prevent the misuse of and illicit traffic in62” cannabis. Based on this 
requirement, Member States use their national forces (usually police) on suspicion of 
transactions with cannabis and search people and property (including schools and 
pupils)63. Regarding these actions, the principle of proportionality should be taken into 
considerations because under the Declaration of Human Rights, privacy of the home and 
individuals is not to be disturbed by the arbitrary interference of state institutions. 
                                           
58 37 th ECDD Agenda item 6.2, 2015. Bertha K. Madras, “Update of Cannabis and its 
medical use”, pp. 21-24. Available on: 
http://www.who.int/medicines/access/controlled-
substances/6_2_cannabis_update.pdf?ua=1&ua=1. Accessed in March 29, 2016.  
59 Supra note 56, Art. 22 and 23.  
60  E. Single, P. Christle, R. Ali, “The impact of cannabis decreminalization in 
Australia and in the US,” Journal of Public Health Policy, 21,2 (2000): pp. 158-159. 
Available on: 
http://www.parl.gc.ca/content/sen/committee/371/ille/presentation/single -e.htm. 
Accessed in March 29, 2016.  
61 Supra note 57, Art. 12.  
62 Supra note 17.  
63 Police Powers in New South Wales, Australia . Available on: 
http://www.legalanswers.sl.nsw.gov.au/guides/hot_topics/drugs/police.ht ml. 
Accessed in March 29, 2016.  
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The last but not least important issue in relation to the Conventions is the lack of 
scientific evidence regarding cannabis. Although this area is not directly related to the 
human rights, it affects information about cannabis use for medical purposes, and 
therefore, gives impact to people who potentially could benefit from the respective 
substance. The main issue is to prove the precise harm to the public health. The main 
reason for the incomplete assessment is that the results depend on several variable 
factors - testing people’s medical history (mental and physical), dosage, frequency of 
use, other medicine taken simultaneously, etc. In addition, the research and proof 
mechanism is getting more complex due to the new synthetic substances that come into 
market and are used more often. All these factors lead to the consequences that 
objective research is getting more difficult to carry out and the outcome in many cases 
is disputable and biased. New research attempts and methods could help to gain more 
comprehensive information about cannabis use and its possible benefits in fighting such 
illnesses as cancer, multiple sclerosis and others.  
From the facts above we can conclude that the overall existing international legal 
control framework of cannabis main deficiencies are: 
 inadequate placement of cannabis in Schedules I and IV alongside with 
particularly dangerous substances; 
 incapacity of the UN to harmonize de facto domestic cannabis regulatory laws of 
the Member States and the international three Convention framework; 
 several Three Convention framework contradictions with the UN human rights 
standards; 
 misuse, unsuitable allocation and defalcation of the government resources to 
combat relatively “small” issues instead of dealing with global crime and drug 
trafficking. 
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II ANALYSIS OF IMPLEMENTED POLICIES IN REAL LIFE - 
THE NETHERLANDS AND THE USA 
In order to understand and be able to analyze the best approach to the cannabis policy 
and its regulation it is important to observe not only the countries whit prohibiting 
cannabis law but also the countries, where the drug policy is more flexible and the 
society more tolerant. The first country chosen to be analyzed is the Netherlands, due to 
its relatively long history of indulgent cannabis policy and public position.  
As for the other examples, the author will observe the cannabis policy and actual 
situation in two of the U.S. states, where the respective substance is legalized - 
Colorado and Washington. Both states have legalized cannabis and now have strictly 
regulated market. In addition, the author will observe the differences between the 
diverse policies and analyze the best approach how to cohere the country’s (state’s) 
aspirations with the international drug policy.  
2.1 The Netherlands 
2.1.1 History and national legislation 
Historically the Netherlands did not have such drug related problems as, for instance, 
the USA or the UK. However, the situation changed in the 19th century as a result of 
Dutch colonies. In early 20th century the Netherlands had become the largest cocaine 
producer in the world and also gained huge profit from opium production.  After the 
Hague Convention in 1912 the Netherlands ratified its own Opium Act, which still 
remains the main law framework of Dutch drug policy64.  
Although the Netherlands is a Member State of UN drug conventions, it has 
established its own, more liberal drug policy regarding cannabis and its related 
substances. The Dutch approach to cannabis regulation was first adopted in 1976 and 
was called “Opium Act Revised”65. The main goal was to separate cannabis, which was 
considered as relatively low-risk substance, from other drugs. The main reason for 
distinguishing “soft” and “hard” substances was to reduce the public and individual 
health risks. In addition, the Netherlands hopped to combat the illicit “hard” drug 
trafficking. In essence the drug policy in the Netherlands emphasizes “compassion and 
treatment for those who develop drug use problems”66. The Dutch national drug policy 
distinguishes two Schedules of regulated substances. The first Schedule contains “hard” 
drugs and the second Schedule includes so-called “soft” drugs - traditional hemp 
                                           
64  Parliament of Canada. National Drug Policy: The Netherlands.  Available on: 
http://www.parl.gc.ca/content/sen/committee/371/ille/lib rary/dolin1-e.htm. 
Accessed in April 6, 2016. 
65  The Netherlands. Opim Act and its Decision. 1928. Available on: 
http://www.cannabis-med.org/dutch/Regulations/Opium_Act.pdf. Accessed in April 
7, 2016. 
66 Supra note 63.  
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products (cannabis, hashish and other cannabis related products). The Dutch authorities 
have allowed possession/preparing/sale/supply/transporting of Schedule II cannabis or 
cannabis related substances up to 5 g and cultivation up to 5 plants67. Small amount 
possession for personal use of cannabis is decriminalized in the Netherlands but sale of 
it is technically prohibited under the Opium Act.  
Besides the Opium Act there are other important Dutch national drug laws and 
regulations that apply to cannabis, such as: 
 Opium Act and its Decision68; 
 Opium Act Directive; 
 Victor Act; 
 Regulated Opium Act Exemptions. 
Since 2001 the institution of Dutch government - Office for Medical Cannabis (OMC) 
produces four types of medical cannabis - Bedrocan, Bedrobinol, Bediol and Bedical, all 
available in the pharmacies Statewide. The medical cannabis is not only supplied to the 
local patients but also to the clients in Italy, Finland and Germany69.  
Cannabis in the Netherlands has on average THC potency of 14.6%, which, 
compared to other markets, is quite high70. However, in 2011 the government advisory 
committee recommended to classify cannabis with more than 15% of THC in Schedule I 
as a hard drug. Nevertheless, the process of adoption is still pending. In 2014 the 
Senate also adopted act against the illegal large-scale cultivation of cannabis. This 
measure was aimed to target the organized crime and illicit trafficking and directly 
affected the Dutch growth shops and other professional breeders71. As the main target 
of the Dutch government is to combat the organized crime the officials proposed a new 
article of Opium Act, which came into force in March 2015 and criminalized large-scale 
production and trafficking of cannabis72. However, starting from the 2010 possession up 
to 15 g of cannabis is no longer a criminal offence.  
Nevertheless, the Netherlands effectively introduced decriminalization of the 
personal, small amount possession of cannabis and started to develop “coffee shop” 
system73. The Dutch government also introduced criteria for legal coffee shops: 
                                           
67 Supra note 64.  
68 Supra note 64.  
69  EMCDDA, Report to the EMCDDA by the Reitox National Focus Point: The 
Netherlands Drug Situation 2014. Available on: 
http://www.emcdda.europa.eu/system/files/publications/994/National%20Report%2
02014%20Final.pdf. Accessed in June 7, 2017. 
70 Ibid. 
71 Supra note 69. 
72 Supra note 69. 
73  Transform: Getting Drugs under control . Cannabis Policy in the Netherlands: 
moving forwards not backwards. Available on: 
https://www.unodc.org/documents/ungass2016/Contributions/Civil/Transform-Drug-
Policy-Foundation/Cannabis-policy-in-the-Netherlands.pdf. Accessed in April 6, 
2016.  
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 in one transaction up to 5 g of cannabis per person are allowed to be sold; 
 prohibition to sell drugs included in Schedule I; 
 no cannabis advertisements are allowed; 
 coffee shops shall not cause any disturbance for the district or the neighbors; 
 prohibited to keep in stock more than 500 g of cannabis; 
Cannabis is not allowed to be sold to people under 18. Moreover, minors are prohibited 
to enter the coffee shop.74 
In 2012 the Dutch coffee shop policy became stricter and two additional criteria 
were adopted - the private club and residence criterion. The main goals were to limit the 
drug-tourism and fight against the organized crime. The private club criteria or “wietpas” 
stated that coffee shops could only give permit of access to a certain group of registered 
coffee shop members. The number of registered members was set to maximum 2000 
members per coffee shop 75 . However, a year later the private club criterion was 
abandoned due to the resident dissatisfaction. The other criterion of residence was 
adopted in 2013 and prohibited non-residents to access the coffee shops. The 
implementation of the restriction depended on the municipalities and the actual 
enforcement was to a limited extent76. A survey in 2014 indicated that 85% of the 
municipalities do not impose the residence criterion77. Currently there are about 700 
coffee shops statewide. The largest density is in the largest cities, especially in 
Amsterdam, where there is one coffee shop per 3000 locals. The Dutch drug policy, 
especially regarding cannabis, inhere other characteristics that other countries are 
elusive to implement.  
2.1.2 Cannabis prevalence in the Dutch population 
The Dutch drug report 2013 revealed that excluding tourist consumption, the local 
population consumed between 44 and 69 tons of cannabis per year. The smallest group 
of intensive users consumed the largest proportion of cannabis - 77% of the total 
amount78. The total use of cannabis including foreigner tourists was estimated to reach 
58 to 143 tons per year 79 . As we can observe in the Table 2 below, the lifetime 
prevalence (proportion of population that at some point in their life used cannabis) 
between 12 and 18 year-olds has decreased in comparison with 2003. The statistics 
about last month use are not so unambiguous and show fickle data. In comparison with 
other European countries, the cannabis use in the Netherlands is twice as high as in 
                                           
74 Supra note 69. 
75  Cahier 2013 summary: The private club and the resindece criterion for Dutch 
coffeeshops. Available on: https://www.wodc.nl/binaries/cahier-2014-12-summary-
and-conclusions_tcm28-71741.pdf. Accessed in June 7, 2017. 
76 Supra note 69.  
77 Supra note 69. 
78  EMCDDA Dutch Drug Report 2013. Available on: 
http://www.emcdda.europa.eu/system/files/publications/770/EMCDDA_NR_2013_Ne
therlands_472317.pdf. Accessed in April 7, 2016.  
79 Ibid.  
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other European countries (15% against 7%)80, however, the consumption of other hard-
profile drugs is lower than in other European countries (4% against 6%)81. In 2003 16% 
of 12-16 year-olds had had their first experience with experimenting with cannabis; in 
2013 the proportion had lowered to 9% and the last data of 2015 show even larger drop 
form 8% to 5% in the current period.  In other words, in the Netherlands, where 
cannabis is relatively softly regulated, the consumers tend to use this “soft drug” instead 
of other European populations, where soft and hard drugs are treated equally and 
temptation to use hard drugs is stronger.  
 
Cannabis use among teenagers, the Netherlands, % 
  1996 1999 2003 2007 2011 
Lifetime 
prevalence  
(12-18 years) 
21.6 19.5 18.7 16.7 17.4 
Last month 
prevalence  
(12-18 years) 
11.1   9.3   8.6   8.1   7.7 
Lifetime 
prevalence  
(15-16 years) 
no data no data 28.0 28.0 27.0 
Last month use 
of cannabis  
(15-16 years) 
no data no data 13.0 15.0 14.0 
Table 2. Source: EMCDDA Report on Drugs, 2013.  
2.1.3 Prevention 
The Dutch government specially pays attention to the high-potency cannabis, which is 
considered to be equal to the hard drugs, which are especially dangerous to people in 
young age82. In 2011 the government started to focus on selective prevention aimed to 
particular risk groups. One of such risk groups was teenagers, which was considered to 
be appropriate group for the preventative measures instead of later addiction treatment 
options.  
Another important field related to prevention is further research of the cannabis 
impact on health, possible harm and gains of its therapeutic value. The Netherlands has 
established government funded research organization “The Netherlands Organization for 
Health Research and Development” (ZonMw) to carry out the scientifically based 
researches on cannabis and other drugs. Since 2005 ZonMw in cooperation with the 
Netherlands Organization for Scientific Research (NWO), the Ministry of Health and 
                                           
80 Supra note 78.  
81 Supra note 78. 
82 Ibid, p. 44.  
 25 
 
Ministry of Justice has launched its first research project “Risk Behavior and Dependency 
Programme”. The main research objects were cocaine and cannabis in relation to risky 
behavior and the target was to “identify key factors that influence the onset, course and 
chronicity of substance dependency”83. In other words, it researched the possible drug 
prevention and treatment methods in accordance with the factors that cause the 
addiction.  It also revealed external factors that at each life stage affected substance 
dependency, especially in the adolescent years of life.  
2.1.4 An insight into economic aspects 
The research data of the public expenditure on drugs, especially on cannabis in the 
Netherlands are rather scarce. The study of 200684 estimates that in 2003 the Dutch 
government spent around 0.5% of its GDP on drug related issues. 75% of the amount 
was spent in law enforcement measures, 13% devoted to treatment, 10% to harm 
reduction and 2% to prevention85. The Opium Act related issues compile relatively small 
amount of the total expenditures on crime. As cannabis related offences are treated as 
“soft drug” offences, they are relatively less costly than those crimes related to the hard 
drugs.  
Another angle of the economic analysis is related to the cannabis tax and coffee 
shop revenue, which gains a considerable amount of state’s profit. There are no official 
government data available about the estimated state tax income from cannabis and 
coffee shop industry. However, the Dutch TV program “Reporter” in 2008 estimated that 
the Dutch government earns around 400 million Euros annually from the country’s 
coffee shop industry86. The same TV research calculated that approximately 610 Dutch 
coffee shops sell about 265.000 kg of cannabis and its resin annually, in total earning 
around 2.8 billion Euros in revenue. In comparison, the latest data from the EMCDDA 
drug report 2016 reveals that the estimated minimum retail value of the EU cannabis 
“grey market” industry has reached 9.3 billion Euros annually (ranging from 8.4 to 12.9 
                                           
83  ERANID. Comparative Analysis of Research into Illicit Drugs Across Europe . 
Available on: 
http://www.eranid.eu/fi leadmin/www.eranid.eu/images/D2.1_Comparative_Analysis
_Report_Final_NSC_comments_included_June_2015.pdf . Accessed in April 11, 
2016.  
84 H. Rigter, “What drug policies cost: drug policy spending in the Netherlands in 
2003”, Addiction, 101 (2006): pp. 323-329.  
85  EMCDDA. Netherlands, country drug report .  Available on: 
http://www.emcdda.europa.eu/countries/netherlands . Accessed in April 7, 2016.  
86  J.P. Grund, J. Breeksema; CVO-Addiction Research Centre. Coffee Shops and 
Compromise, 2013. Available on: 
https://www.opensocietyfoundations.org/sites/default/files/coffee -shops-and-
compromise-20130713.pdf. Accessed in April 10, 2016.  
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billion Euros p.a.), which equals 38% and is the largest share of the European illicit drug 
market87.  
The key issues here are, however, not the size of the industry, but the origin of 
the cannabis and the ways in which the government tax revenue is spent. In regard to 
the first, the Reporter estimates that about 40% of the total cannabis is cultivated 
locally in the Netherlands while the rest of the demand is satisfied by exported, untaxed 
cannabis via black market. In other words, it is believed that the largest proportion of 
the cannabis market is supplied through organized criminal markets that import foreign 
cannabis to the Netherlands, avoiding the official tax and government authorities. In 
addition, this also means that all the regulations valid in the Netherlands are not 
respected and the cannabis available in the market contains substances with unknown 
origin and content. Regarding the issue of the use of the government income from the 
cannabis and coffee shop industry tax, this question is very complex and is actually not 
possible to solve legally under the existing international law.  
2.1.5 Dutch cannabis policy advantages 
The Dutch drug policy regarding cannabis and its resin is one of the most liberal in the 
Europe. In the previous text the data comparison reveals that cannabis use in the 
Netherlands is higher than in the other EU countries where cannabis is treated more 
stringed. However, the prevalence of stronger drugs is higher in other EU countries. This 
conclusion leads us to a dilemma situation - whether to mitigate the cannabis regulation 
in order to encourage people to choose softer substances or leave the existing control 
mechanism and observe the consequences of larger consumption of hard drugs. The 
Netherlands has chosen the first option in order to reduce the harm exposed to the 
public because the history has showed - people still will be using different drugs even if 
they are harshly banned. The only way to prevent the harmful effect to the public health 
is to create considerate and intelligent control mechanism to regulate the substances 
that enter the consumption market.  
By softening policy towards the small amount possessors and cultivators of the 
cannabis the Dutch police is able to allocate its forces to more important areas and 
combat large-scale organized drug cartels. One of the crucial points in the Dutch and 
generally in the EU drug policy is international cooperation to ensure that the organized 
trafficking groups and other criminal organizations do not grow in power and in 
effectiveness. This determination is particularly important in Schengen area where 
officially there is no interstate border control. In some research, carried out by Dutch 
civil servant working group, it is estimated that if the coffee shop business would be 
                                           
87  EMCDDA. EU Drug Markets Report: Strategic Overview 2016. Available on: 
http://www.emcdda.europa.eu/system/files/publications/2374/TD0416161ENN_1.PD
F Accessed in April 11, 2016.  
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regulated more effective, the Dutch police and justice system would save up to 160 
million Euros and the tax income would increase by approximately 260 million Euros88.  
2.1.6 Cannabis policy loopholes in the Netherlands 
The liberal Dutch cannabis policy leads to several problems related to drug tourism and 
personal cross-border cannabis trafficking. Previously mentioned data from the Dutch 
Drug Report 2013 reveals that the domestic consumption reached approximately 44-69 
tons of cannabis in 2013 while the total consumption was 58-143 tons of the respective 
substance. This means that on average foreign tourists consumed 14-74 tons of 
cannabis, which equals to 24-52% of the total consumption. In other words, the highest 
estimates show that the foreign drug tourists consume more cannabis that the domestic 
population. This issue is particularly complex in the Schengen zone due to its lack of 
boarder control. In this context, the Netherlands is facing objections from the 
neighboring countries, where the border guards regularly carry out vehicle inspections 
with the purpose to alienate prohibited substances. 
The Dutch cannabis policy regarding coffee shops presents ambiguous paradox. 
On the one hand, the front-door sale and possession of small amounts of cannabis is 
decriminalized and de facto licit. On the other hand, the back-door cultivation and 
supply to coffee shops is still illegal and strictly prohibited. This ambidextrous policy 
gives coffee shops almost no opportunity to operate their business in a “clean” way and 
creates possible loopholes for criminal actions and fraudulence.  
The Netherlands is facing lack of information about the actual cultivation process 
of the local cannabis plants. The EMCDDA Drug Report 2016 suggests a new dangerous 
trend to be use in cannabis cultivation- butane gas from the United States, which again 
affects the human health in a harmful way89. Moreover, lately a connection between so-
called Dutch “grow shops” and organized criminal groups is detected. These facts have 
led to the more stringed control measures carried out by the Dutch authorities in 
collaboration with other European countries.  
As it is mentioned before, the Dutch cannabis tax system lacks transparency and 
targeted allocation of the resources they earn from the coffee shop industry. They do 
fund the different drug treatments and other health facilities but it is carried out rather 
chaotically, without stringed intention and concrete action plan. Instead of setting 
specified measures and short- middle- and long-term goals, the Dutch drug policy only 
considers general targets, such as “well-being of the society” and “protection of public 
health”. This kind of policy is not likely to be effective in a long-term and does not 
guarantee sustainable drug regulatory system.  
                                           
88  Transnational Institute. Cannabis policy reform in Europe. Available on: 
http://druglawreform.info/images/stories/documents/dlr28.pdf . Accessed in April 
12, 2016.  
89 Supra note 87. 
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2.2 The U.S. federal and state level cannabis policy 
In the United States exists two tier legislative system - at the higher level is federal law 
and at the local level applies state law. At federal level the U.S. has prohibited any kind 
of cultivation, production, sale and possession of many drugs that are intended purely 
for recreational use with exceptions of alcohol and tobacco. There are, however, several 
exceptions regarding medical use of particular substances. One of the most 
contradictory regulated substances is cannabis, which now gains more and more 
attention due to the inconsistency in its regulation at federal and state law levels.  
The history of official federal drug law regarding cannabis started in 1937 with 
Marijuana Tax Act90, which introduced prohibitive taxation regime of cannabis. This Act 
stated that 
Every person who imports, produces, compounds, sells, deals in, dispenses, 
prescribes, administers, or gives away marihuana shall (…) each year pay (…) 
special taxes91. 
Officially this Tax Act allowed to carry out transactions related to cannabis but in the 
reality the transfers were taxed $100 per ounce, which was a massive tax rate and 
financially was not affordable. The only objection was made by the American Medical 
Association, which argued that there was no scientifically proven evidence to confirm the 
federal ban on cannabis92.  
In 1970 the Tax Act of 1937 was replaced by the Comprehensive Drug Abuse 
Prevention and Control Act of 1970 (Controlled Substances Act or CSA)93, which was 
enforced by Drug Enforcement Administration (DEA). In the CSA the substances were 
placed into five Schedules - Schedule I being the most harmful with no therapeutic 
value. Cannabis was placed in Schedule I, part C, which states that “There is a lack of 
accepted safety for use of the drug or other substance under medical supervision”94. In 
1980s the drug regime became harsher and in 1984 the Congress adopted 
Comprehensive Crime Control Act of 198395. The main goal of this act was to ensure the 
public safety.  Later on the U.S. adopted Anti-Drug Abuse acts of 1986 and 1988 that 
defined minimum penalties for possession of and transactions with small amount of 
drugs, including cannabis.  
                                           
90  Full text of the Marijuana Tax Act of  1937. Available on: 
http://www.druglibrary.org/schaffer/hemp/taxact/mjtaxact.htm. Accessed in April  
12, 2016.  
91 Ibid. 
92 J. Richard, B.Ch.H. Whitebread, II, “The Marijuana Conviction”, 1999, pp. 164-
172. 
93  Comprehensive Drug Abuse Prevention and Control Act of 1970. Available on: 
http://legcounsel.house.gov/Comps/91-513.pdf. Accessed in: April 12, 2016.  
94 Ibid. 
95 Legislative history of the Comprehensive Crime Control Act of 1983. Available on: 
https://www.fd.org/sites/default/files/criminal_defense_topics/essential_topics/sen
tencing_resources/deconstructing_the_guidelines/legislative -history-of-the-
comprehensive-crime-control-act-of-1983.pdf. Accessed in June 7, 2017. 
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Despite all the prohibitions and restrictive legislation at federal level, the states 
are willing to experiment with new drug policies, especially regarding cannabis for 
medical and also for recreational use. Until now 23 U.S. states and Washington D.C. 
have legalized cannabis for medical use (see Appendix 3). Moreover, states of Alaska, 
Colorado, Oregon, Washington and cities of Portland, South Portland, Michigan, Maine 
and Keego Harbor have legalized not only cannabis for medical purposes but also for 
recreational use. In total, only 22 U.S. states have remained stringed in their position 
against cannabis. Nevertheless, at federal level the U.S. has not deliberated its 
restrictive policy regarding cannabis. Since the U.S.-wide there exist so different 
cannabis legislations and law based regulations, it is important to observe the most 
significant of them and analyze, which approach is the most suitable for appropriate 
cannabis regulation. In order to be able to carry out such analysis, the author will 
evaluate states of Colorado and Washington - the first two of the U.S. states and 
jurisdictions worldwide that have legalized cannabis and started to regulate its market.  
2.3 State of Colorado 
2.3.1 History and current cannabis legislation 
Colorado state legislative history regarding cannabis begun in 1917, when its local 
government made the possession and cultivation of the respective substance a criminal 
offence. In 1975 Colorado along with such states as California, Mississippi, New York 
and others decriminalized cannabis based on president Nixon’s administration federal 
commission report of 197296 (other known as Shafer Commission). The most significant 
recommendation of this report was to decriminalize the possession and non-profit 
transactions related to cannabis. During the existence of the Shafer Commission it 
administrated the most comprehensive control mechanism of cannabis in the U.S. 
history. Colorado state government ruled that personal possession of 28.35 g of 
cannabis would be fined with $100 penalty and possession or any transaction with more 
than 28.35 g of cannabis would we counted as harsh offence.  
However, the times were changing and in 2000 Colorado voters with 54% of the 
vote passed the legalization of medical cannabis. The Amendment 20, other known as 
Medical Use of Marijuana Act was adopted and came into force97. This amendment 
allowed people with “debilitating medical condition”98 cultivation, possession and use of 
cannabis. The Act defined that patients are authorized to possess 28.35 g of cannabis 
and cultivate up to 6 plants. Cannabis legislation also set limit of THC potency of the 
                                           
96  CSDP Research Report. Nixon Tapes Show Roots of Marijuana Prohibition: 
Missinformation, Culture Wars and Pejudice , 2002. Available on: 
http://www.csdp.org/research/shafernixon.pdf . Accessed in April 13, 2016.  
97  Miscellaneous Art. XVIII, Section 14. Medical use of marijuana for persons 
suffering from debil itation medical conditions . Available on: 
https://www.colorado.gov/pacific/sites/default/files/CHEIS_MMJ_Colorado -
Constitution-Article-XVIII.pdf. Accessed in April 13, 2016.  
98 Ibid.  
 30 
 
edible cannabis products - 10 mg of THC per serving and maximum 100 mg per 
package. The system was administered by Colorado Department of Public Health and 
Environment (CDPHE), which on a patient’s request issued cannabis permits based on a 
specialist’s recommendation99. In the first years of medical cannabis legalization its use 
did not change dramatically, however, starting from 2009 the use of medical cannabis 
increased.  
In 2010 House Bill 1284, which legalized medical cannabis centers, cannabis 
cultivation and manufacturing of edible products consisting cannabis100 came into force. 
By 2012 there were 532 licensed centers statewide and 108.000 officially confirmed 
patients with legal access to medical cannabis101. Finally, in November 2012 Colorado 
voters with 55% in favor of the Amendment 64 legalized cannabis in the state of 
Colorado for recreational use. This amendment allowed persons over the age of 21 to 
cultivate, possess and use cannabis for recreational purposes. The amendment set limits 
of possession to no more than 28.35 g per person on a single transaction and allowed 
growing of no more than 6 cannabis plants. The new regulation also authorized 
cannabis vendor stores, cultivation and testing places as well as edible manufactures102. 
The amendment stated that cannabis production must be taxed similarly as it is done by 
the alcohol, and the first $40 million of the annual revenue shall be used for funding 
public school construction and renovation103.  
In early 2013 the Governor Hickenlooper developed House Bill 13-1325, which 
regulated more precisely the details of allowed cannabis consumption. First, it defined 
that maximal limit of THC in a driver’s blood could not exceed 5 ng (nanogram) per ml 
of blood. Second, it stated that non-resident of the state was not allowed to buy more 
than 7 g of cannabis in one transaction. Third, it suggested proposing referendum 
regarding the desirable tax rate on the respective substance104. In September 2013 the 
Colorado Department of Revenue enforced final regulation of recreational cannabis 
commercial transactions. This document mostly regulated issues related to such 
disciplines as licensing (premises, entities), storage and transportation, record keeping 
                                           
99 Rocky Mountain HIDTA report. The Legalization of Marijuana in Colorado, 2013. 
Available on: 
http://www.rmhidta.org/html/final%20legalization%20of%20mj%20in%20colorado
%20the%20impact.pdf. Accessed in April 13, 2016.  
100 Second Regular Session Sixty-seventh General Assembly of State of Colorado. A 
bill for an Act concerning regulation of medical marijuana . Available on: 
http://www.leg.state.co.us/clics/clics2010a/csl.nsf/fsbillcont/0C6B6577EC6DB1E887
2576A80029D7E2?Open&file=1284_01.pdf. Accessed in April 13, 2016.  
101 Supra note 99, p. 4.   
102  Amendment 64. Use and Regulation of Marijuana. Available on: 
http://www.fcgov.com/mmj/pdf/amendment64.pdf . Accessed in April 13, 2016.  
103 Ibid.  
104 First regular session sixty-ninth general assembly of state of Colorado, House 
Bill 13-1325. Available on: 
http://www.leg.state.co.us/clics/clics2013a/csl.nsf/billcontainers/746F2A0BF687A54
987257B5E0076F3CD/$FILE/1325_rer.pdf . Accessed in April 13, 2016.  
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and inventory, advertisement, marketing, packaging and, of course, medical 
differentiation between various types of cannabis105.  
In late 2013 so called “Proposition AA” on retail marijuana tax was passed and 
adopted by 65% of Colorado voters in favor. It mainly proposed four important 
recommendations on cannabis taxation rates and the advisable purposes for utilization 
of the respective tax revenue. Firstly, it suggested applying 15% state tax on the 
average sales price when cannabis is first sold. The annual revenue of the first $40 
million shall be invested in the public school construction and renovation. Secondly, it 
enforced 10% state sales tax on retail cannabis and it consisting products, additionally 
taking into account the existing 2.9% state sales tax. The earnings from this position 
shall be devoted to cannabis industry related education, information, health and public 
safety expenditure. Thirdly, the proposition suggested that 15% of the income earned 
form the 10% state sales tax should be devoted to cities and locations, where the actual 
retail of cannabis took place. Fourthly, the state is allowed to increase tax rate on 
cannabis as long as the rate of either tax is not higher than 15%. In addition, the state 
of Colorado also introduced different fees for diverse positions: 
 Application fee for cannabis vendor store, growing facility, production - $5.000, 
for testing facility - $1.000; 
 License fee for cannabis vendor store - $3.000, for cultivation facility - $2.200, 
for cultivation of plants (2.601-6.000 plants) - $.4000, for cultivation of plants 
(6.001-10.200 plants) - $8.000, for production - $2.200, for testing facility -
$2.200; 
 Renewal License Fee for retail, cultivation, production and testing the base 
license fee + renewal fee of $300 
 Renewal License fee for cultivation of plants (2.601-6.000 plants) and (6.001-
10.200 plants) the base license fee + doubled renewal fee ($600).  
 Administrative fees  
o Transfer of proprietorship - New owners- $2.000; 
o Transfer of proprietorship - Reallocation of proprietorship- $800; 
o Change of Corporation of LLC structure per person - $800 
o Change of trade name - $40; 
o Change of location applicant fee - $500; 
o Modification of license premise - $120; 
o Duplicate business license - $40 
o Duplicate occupational license - $10 
o Indirect financial interest background investigation - $150; 
o Off premise storage permit - $2.200; 
                                           
105  Colorado Department of Revenue. Permanent Rules Related to the Colorado 
Retail Marijuana Code, 2013. Available on: 
https://www.colorado.gov/pacific/sites/default/files/Retail%20Marijuana%20Rules,
%20Adopted%20090913,%20Effective%20101513%5B1%5D_0.pdf. Accessed in 
April 13, 2016.  
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o Subpoena fee - $200106. 
In general, this comprehensive fee and tax system both gives more freedom to 
cannabis market and in the same time limits its extent by maximizing the control 
measures. In this way the government of Colorado tries to kill two birds with one stone- 
gain the maximal potential benefit from the respective industry and keep the cannabis 
policy “public health friendly”. 
2.3.2 State law in conflict with federal legislation 
Possibly the largest challenge dealing with the development and adoption of the 
Colorado cannabis law has been its inconsistency with the federal legislation, especially 
with the CSA. The U.S. federal Department of Justice was concerned about Colorado 
new initiative and requested to cooperate in three fields:  
 continued enforcement of CSA; 
 banking system accessibility to the cannabis business; 
 federal business expense tax adaption to the cannabis business. 
Regarding the first criterion of CSA, the state of Colorado undertook to ensure robust 
cannabis policy and respect such requirements as: 
 minor prevention from cannabis use; 
 combat against criminal bodies in cannabis business; 
 prevent state-authorized activity regarding any kind of trafficking or any other 
illegal activities; 
 penalize and exclude driving under influence (in this case cannabis); 
 prevent public cannabis use and ensure environmental safety. 
Due to the risk of money laundering and other illicit activities, the federal government 
required Colorado to ensure that the cannabis business would have access to banking 
system. This requirement would also help state authorities to control the cannabis 
business, their accounts, revenues and audit tax payments. In 2014 the U.S. Treasury 
Department’s Financial Crimes Enforcement Network (FinCEN) published guiding 
principles to explain Bank Secrecy Act (BSA) and its capacity dealing with cannabis 
related business. FinCEN also created stricter obligations regarding Suspicious Activity 
Reports (SARs) for the financial institutions dealing with cannabis industry. 
Regarding the third issue related to taxation, cannabis business possessed higher 
taxable income. To avoid any shortcomings, Colorado with its House Bill 13-1042107 
ruled that starting from 2014 the cannabis business entities would be able to claim a 
state income tax deduction for business expenses that are also appropriate to be 
                                           
106  2013 State Ballot, Proposit ion AA. Retail Marijuana Taxes. Available on: 
https://www.colorado.gov/pacific/sites/default/files/2013%20Blue%20Book%20ENG
LISH%20INTERNET.pdf. Accessed in April 13, 2016.  
107 First regular session sixty-ninth general assembly of state of Colorado, House 
Bill 13-1042. Available on: 
http://www.leg.state.co.us/clics/clics2013a/csl.nsf/fsbillcont/D12657F864EC4B2F87
257AEE0058844F?Open&file=1042_01.pdf. Accessed in April 14, 2016.  
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claimed as federal income tax deduction108. The Image 3 presents detailed distribution 
of Colorado cannabis tax structure. 
Image 3. Source: Office of Marijuana Coordination, Colorado. 
 
  
                                           
108  D. Blake, J. Finlaw, “Marijuana Legalization in Colorado: Learned Lessons”, 
Harward Law and Policy Review, pp. 361-380. 
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2.3.3 An insight into economic aspects 
The medical cannabis was imposed by 2.9% state sales tax, from which the revenue 
goes to the Marijuana Tax Cash Fund (MTCF). This fund is responsible for investment in 
cannabis regulatory mechanisms improvement and other costs connected to the 
respective substance. In January 2016 Colorado earned $897.973109 from the medical 
cannabis taxation. 
The recreational cannabis was imposed by three different tax rates. First, there is 
regular state sales tax of 2.9%, which in January 2016 composed $1.584.113 earning of 
the state of Colorado. In total, in January Colorado earned $2.482.086 form the state 
sales tax. Comparing to January 2015, when the total state sales tax on cannabis 
reached $1.874.283, the revenue has increased by 51.6%. In total, in 2014 the sales tax 
revenue on cannabis was $12.219.878, in comparison with 2015, when the state earning 
reached $17.930.141, there has been substantial increase of 46.7%. These data allows 
us to forecast that in 2016 the state sales tax revenue increase will continue.  
Next tax rate, which was imposed to the retail cannabis, is 10% special state 
sales tax (or retail marijuana sales tax), from which the revenue is also delivered to the 
MTCF. The retail marijuana sales tax consists of three components - local government 
distribution (15% of total), marijuana tax cash fund transfer (85% of total) and 
collections not yet allocated. In 2014 the total retail cannabis sales tax revenue was 
$21.341.444, whereas in 2015 it reached $36.906.479 creating 72.9% increase in 
comparison with the previous year110. The third tax rate group is retail marijuana excise 
tax of 15%. This tax rate also consists of three main components - public school capital 
construction assistance fund transfer, marijuana tax cash fund transfer and collections 
not yet allocated. In 2014 the excise tax revenues reached $10.326.161, whereas in 
2015 it peaked to $21.390.975, which was 107.2% more than in last year. Additionally, 
there is duty on licenses and fees, which in 2014 earned $8.682.599 state income and in 
2015 $9.047.776 (4.2% rise in comparison with the previous year). In total, state 
earnings from cannabis taxation in 2014 were $52.570.081 ($39.033.365 devoted to 
cash fund transfers) whereas in 2015 it peaked to $85.275.371 ($58.451.059 into cash 
funds). In other words, in period 2014-2015 the total state income from cannabis tax, 
licenses and fees increased by 62.2% and the investment devoted to the different funds 
in the respective period increased by 49.7%111.  
Cannabis tax revenue apportionment can be observed in the Chart 1 below. The 
largest proportion of the funding of $14.4 million was spent for regulatory supervision, 
more than a quarter of the funds was devoted to preventative measures regarding 
youth use of cannabis ($10.9 million). Almost a fifth of the revenue or $7.5 million was 
used for treatment facilities and programs, 16% or $7 million were used for public 
                                           
109 Colorado Department of Revenue. Colorado Marijuana Tax Data, January 2016 . 
Available on: https://www.colorado.gov/pacific/revenue/colorado-marijuana-tax-
data. Accessed in April 13, 2016.  
110 Ibid.   
111 Supra note 109.  
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health and the rest were used for law enforcement, public safety and administrative 
coordination.  
 
 
Chart 1. Source: Department of Revenue Funding, Colorado. 
2.3.4 Cannabis prevalence 
Based on statistics from 2013-2014, 7.22% of the teenagers aged 12-17 in the U.S. 
consumed cannabis in the previous month, in comparison, in Colorado these data 
reached 12.56%. Cannabis use in Colorado among 12 to 17 year-olds has changed a 
little in period 2012-2014 (11.16% in 2012 and 12.56% in 2014). Compared to U.S. 
wide data - the average past month use of cannabis reaches 7.15% of the 12-17 year-
olds. Risk of harm from smoking cannabis once a month data, however, in Colorado is 
on average lower than U.S. wide and in period 2012-2014 have increased. In 2012 the 
risk in Colorado was estimated to be 19.58 (U.S. wide 25.34) and in 2014 the risk was 
even lower in Colorado reaching 17.04 (23.54 on average in the U.S.). This trend shows 
that even with the relaxed cannabis policy the youth health harm does not increase in 
Colorado. In other words, the state’s preventative measures and public health protection 
policy is showing positive effect on youth protection from the potential cannabis harm. 
The data from the National Survey on Drug Use and Health reveal that Colorado is 
among those states where cannabis level of use has remained unchanged in period 
2012-2014112.  
                                           
112 Substance Abuse and Mental Health Service Administration CGHSQ Report, 2015. 
Available on: 
http://www.samhsa.gov/data/sites/default/files/report_2121/ShortReport -2121.pdf. 
Accessed in April 14, 2016.  
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2.3.5 Prevention 
Colorado cannabis preventative measure policy works from different angles. First, the 
state has prohibited commercialization of cannabis industry. Promotion, advertising and 
marketing is strictly limited, in many occasions even prohibited. This policy comes from 
the previous experience with the alcohol and tobacco, where the commercials and 
promoting campaigns were made appealing to the public, especially the youth and 
encouraged them to sample the respective products. Another reason behind this 
prohibition is the previous experience with tobacco products, where the softly regulated 
industry expanded enormously and gained overwhelming power over law and policy 
makers by lobbying and corruption. 
Another important aspect of preventative measures is to prevent juvenile 
consumption. As the young people are at higher risk of abuse and other harmful effects 
it is crucial to prevent them from early use of the respective substance. It is also 
believed that the adolescents more often mix different substances and are willing to 
sample cannabis with high level of THC. This argument also speaks against cannabis 
market share of edibles, which are frequently made in form of candies and the user 
cannot evaluate how much of the active substance he/she is actually consuming. As 
Colorado legislation permits the production and sale of such edibles, their availability to 
the youth is very controversial issue. The state of Colorado also regularly monitors the 
latest statistical data about cannabis prevalence among adolescents and act accordingly 
to the results.  
2.3.6 Advantages of the cannabis legislation in Colorado 
The largest advantage of Colorado cannabis regulation is its detailed tax system and tax 
revenue investments into problematic public fields. The differentiated, proportional tax 
rates and distinguished tax regime of cannabis for medical and for recreational purposes 
show that it is possible to create proportionate and considerate cannabis taxation, which 
in the same time benefits other fields, such as medicine and education. Colorado also 
sets successful example how taxation can decrease the black market and the importance 
of criminal organizations regarding cannabis industry. 
One of the benefits of legalizing cannabis is the decrease of unemployment, 
which is observed taken into account the annual statistics. The data of the U.S. Bureau 
of Labor statistics reveal that the unemployment is steadily decreasing from the year 
when cannabis was legalized (in October 2015 unemployment rate was 3.6%, in the 
March 2016 it dropped to 2.9%). In other words, the more people are employed, the 
faster is the state’s economy growing and developing. This tendency shows that 
Colorado is one of the fastest growing state economies in the U.S. and, taking into 
account its future potential, the growth rates are believed to increase. All and all, the 
tendency of economic expansion and no serious harmful side effects of the cannabis 
legalization can be potentially strong reason for other states to reconsider their attitude 
towards the respective substance.  
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After the legalization of cannabis it related arrests have dropped. The reason, of 
course, is that the retail, cultivation and possession of certain amount of cannabis and it 
related products are legally allowed. This means that the judicial and police system can 
focus its resources on more complex and more serious issues such as combating 
organized crime or street gangs. Data about other crimes with indirect (or possible) 
cannabis involvement are contentious. The official Colorado crime statistics shows that 
the violent crime rates in Colorado are lower than the average U.S. rates and there have 
been no significant changes in the rates after the legalization of cannabis (in 2010 
323.2, in 2012 302.0, in 2014 305.7 crimes per 100.000). This means that, basically, the 
overall crime situation in Colorado has not changed or even has improved after the 
legalization of cannabis.  
2.3.7 Loopholes of the cannabis policy in Colorado 
One of the unsolved issues regarding use of cannabis is driving under influence of the 
respective substance. Since 2012 when Colorado legalized commercial transactions with 
cannabis the statistical data have been divisive and in many categories unpromising. 
Although the overall fatalities on roads have not changed significantly, the proportion of 
cannabis-involved fatalities in period 2011-2014 has increased by 4%. The number of all 
drivers tested positive for drug use the cannabis related proportion also increased in 
period 2010-2014 form 56% to 68% of all drug positive tested drivers113. 
This tendency shows the need for better information for drivers, stricter 
regulation and fine system for those who are caught driving under cannabis influence. 
The system should be created similarly as to the one regulating the alcohol consumption 
and use behind the wheel.  
Another typical problem is to determine precise THC concentration in blood. The 
THC testing methods are more complex that those used in alcohol control and, similarly 
to alcohol, cannabis has different effects to different individuals over time. Setting 
allowed THC limits is not enough if the control is not comprehensive and does not 
involve police force and their training to recognize potential drug influenced drivers.   
Amendment 64 and Amendment 20 have created a gap in Colorado cannabis 
policy regarding medical cannabis and its caregivers. Colorado Department of Public 
Health and Environment defines “primary caregiver” as 
Person other than the patient and the patient’s physician, who is eighteen years 
of age or older and has significant responsibility for managing the well-being of a 
patient who has a debilitating medical condition114. 
                                           
113 Colorado Department of Transportation, Drugged Driving Statistics. Available on: 
https://www.codot.gov/safety/alcohol -and-impaired-
driving/druggeddriving/drugged-driver-statistics. Accessed in June 7, 2017. 
114 Colorado Department of Public Health and Environment, proposed amendments 
to 5 CCR 1006-2, Medical Use of Marijuana, 2014. Available on: 
https://www.colorado.gov/pacific/sites/default/files/MMR%20HRG%20Packet%208.
8.14.pdf. Accessed in April 14, 2016.  
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A caregiver is officially allowed to cultivate 6 cannabis plants on behalf of the each 
registered medical cannabis patient. Due to this ambiguity in legislation, there are 
operating many unlicensed cultivation places claiming to be caregivers and developing 
new form of black market. However, if such plantation is caught it can be easily charged 
because of the facts that in Colorado legislation one caregiver is allowed to have no 
more than five patients and for each patient are allowed no more than 6 cannabis 
plants. Theoretically, if the caregiver himself has a permit to cultivate 6 cannabis plants, 
in total he/she can grow up to 36 plants of cannabis.  
Another form of innovative cannabis cultivation within the legal framework is 
development of so called “cooperatives”. The idea behind this model is to gather as 
many over 21-year-olds together and make an agreement to cultivate allowed amount 
of cannabis plants (6 per person) in order to maximize the return on investment. This 
method falls under “home cultivation”, which in Colorado is unregulated. Theoretically, 
such cooperatives could become larger and even outcompete the official cultivation 
facilities. The government of Colorado should pay additional attention to such 
communities and control whether such cooperatives pay license costs and are 
appropriately regulated.  
In addition, in 2014 state financed study “Market Size and Demand for Marijuana 
in Colorado” carried out by the Marijuana Policy Group for the Colorado Department of 
Revenue’s Marijuana Enforcement Division. The research revealed unpleasant data 
regarding cannabis consumption - in 2014 cannabis demand reached 130 metric tons, in 
the same time the legal cannabis market could only account for 77 metric tons115. This 
data discrepancy shows that the illegal cannabis related transactions have not been 
interrupted and the black market is still present. In context with the above stated facts, 
this black market share could be supplied with the unregulated home growths.  
Other Colorado surrounding states are affirming that the local cannabis 
legislation in Colorado is in conflict with their cannabis law and, in general, does not 
comply with the federal law. In late 2014 states of Nebraska and Oklahoma claimed U.S. 
Supreme Court to annul Colorado legislation Amendment 64 regarding cannabis 
legalization116. Both states argued that by cannabis legalization and commercialization 
Colorado has infringed federal law and jeopardizes other states’ policies against 
cannabis. In addition, cannabis, which is legal in Colorado but remains illicit in other 
states, is being trafficked across respective state borders thereby damaging other states. 
The U. S. Supreme Court refused to hear this lawsuit as argument mentioning that 
cannabis policy is intra-state decision of Colorado and both states of Nebraska and 
                                           
115  Colorado Department of Revenue. Market size and demand for marijuana in 
Colorado. Available on: 
https://www.colorado.gov/pacific/sites/default/files/Market%20Size%20and%20De
mand%20Study,%20July%209,%202014%5B1%5D.pdf . Accessed in April 18, 2016.  
116 Supreme Court of the United States, Nebraska, Oklahoma v. Colorado. Available 
on: https://www.ok.gov/oag/documents/NE%20%20OK%20v%20%20CO%20-
%20Original%20Action.pdf. Accessed in April 14, 2016.  
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Oklahoma have no rights to intervene into the legislation of Colorado. The solicitor G. D. 
Verrilli added, that Nebraska and Oklahoma cannot prove the fault of Colorado for 
injuring their sovereign interest nor can they prove that Colorado as a state entity has 
authorized any individual to traffic/transport cannabis in their territories.  
All in all, Colorado has created its own cannabis policy and control standards. Its 
government has critically considered all the pros and cons and has chosen to have more 
flexible approach regarding the respective substance.  
2.4 State of Washington  
2.4.1 History and existing cannabis legal framework 
The first official state level legislative document related to cannabis was presented to 
the public in 1998 and was called Initiative 692 or other known as Medical Use of 
Marijuana Act 117 . This initiative was approved by 59% of voters 118  and the act 
acknowledged that “some patients with terminal or debilitating illnesses, under their 
physician’s care, may benefit from the medical use of cannabis”119. In other word, the 
initiative legalized medical cannabis for personal use with requirements that the person 
has received permit form the physician and cannabis is supplied up to 60-days.  
In 2007 the State of Washington Department of Health in Senate Bill 6032 stated 
more precise rules of quantity for 60-day supply of medical cannabis120. It also stated 
the health conditions and disease parameters for which cannabis use was legal. In 2009 
the State of Washington adopted another Senate Bill 5798 that expanded the list of 
professionals who were authorized to prescribe medical cannabis121. In addition, in 2011 
the Senate Bill 5073 was adopted. 122  This Senate Bill established regulatory 
requirements for licensed production and distribution of medical cannabis.  
The most important breakthrough came in 2012 when the residents of 
Washington passed Initiative 502, which legalized cannabis for recreational use for 
                                           
117 State of Washington, U.S. Initiative 692 (Medical Use of Marijuana Act), 1998. 
Available on: https://www.sos.wa.gov/elections/init iatives/text/i 692.pdf. Accessed 
in April 18, 2016.  
118 Washington State Senate. History of Washington State Marijuana Laws. Available 
on: 
http://www.ncsl.org/documents/summit/summit2015/onlineresources/wa_mj_law_hi
story.pdf. Accessed in April 18, 2016.  
119 Supra note 117, Section 2 “Purpose and intent”.  
120  State of Washington. Senate Bill 6032, 2007. Available on: 
http://lawfilesext.leg.wa.gov/biennium/2007-08/Pdf/Bil ls/Senate%20Bills/6032.pdf . 
Accessed in April 18,2016.  
121  State of Washington. Senate Bill 5798. Available on: 
http://lawfilesext.leg.wa.gov/biennium/2009-10/Pdf/Bil ls/Senate%20Bills/5798.pdf . 
Accessed in April 18, 2016.  
122  State of Washington. Senate Bill 5073. Available on: 
http://lawfilesext.leg.wa.gov/biennium/2011-12/Pdf/Bil ls/Senate%20Bills/5073.pdf . 
Accessed in April 18, 2016.  
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adults reached 21 years 123 . This initiative established tight regulatory framework of 
cannabis licensing, taxation, cultivation, distribution and possession. The packaging, 
labeling and other cannabis related activities had to be coordinated under the state’s 
law124. All the taxation, fee and licensing related income should create a “dedicated 
marijuana fund”, which then would devote its resources to “education, health care, 
research and substance abuse prevention125. 
The Initiative 502 stated that person, who is 21-years-old or more, is allowed to 
deliver, distribute and sale following amounts of cannabis and it related products: 
 up to one ounce (approx. 28 g) of smokable cannabis; 
 up to 16 ounces (456 g) of solid edible; 
 up to 72 ounces (2 kg) of liquid edible and 
 up to 0.24 ounces (6.8 g) concentrates126. 
Individuals are allowed to cultivate no more than 15 medical cannabis plants in a 
housing unit if he/she has received an official permit, otherwise, house cultivation 
remains illegal. Any kind of consumption of cannabis in public is also prohibited and can 
be panelized by up to $100 fine. The Initiative 502 also regulates driving under drug (in 
this case) cannabis influence. Any individual who is driving a motor vehicle is prohibited 
to consume cannabis if the concentration of THC in blood exceeds 5 ng to 1 ml or if the 
individual shows apparent behavior signs of intoxication127. In Washington cannabis is 
allowed in smokable, concentrated and edible state of aggregation, except the edibles 
that are appealing to children like colorful candies and cookies.  
State of Washington also regulated the THC potency in the cannabis products. 
For edible products the limit is 10 mg per serving and maximum 100 mg per package. 
Other products have limit of 60% of THC per unit of the respective substance. In 2015 
Washington supplemented existing cannabis legal framework with several clarifications. 
First, the Senate Bill 5052128 applied the legislative mechanism, developed in Initiative 
502, to the poorly regulated medical cannabis market, which required cannabis vendors 
to obtain permit in order to be able to sell medical cannabis to lawfully qualified 
patients129. The new regulation also replaced uncontrolled cannabis dispensaries with 
maximum four-member cooperatives starting from the July 1, 2016, which must be 
registered with the Liquor and Cannabis Board (LCB)130. In addition, Senate Bill 5121 of 
                                           
123 State of Washington. Init iative Measure No. 502, 2012, Section 1(3). Available 
on: http://sos.wa.gov/_assets/elections/init iatives/i502.pdf . Accessed in April 18, 
2016.  
124 Ibid, Section 4.  
125 Supra note 123, Section 1(2). 
126 Supra note 123, Section 15(3).  
127 Supra note 123, Section 31.  
128  State of Washington. Final Bill Report 2SSB 5052, 2015. Available on: 
http://lawfilesext.leg.wa.gov/biennium/2015-16/Pdf/Bil l%20Reports/Senate/5052-
S2%20SBR%20FBR%2015.pdf. Accessed in April 18, 2016.  
129 Ibid, p. 3.  
130 Supra note 128, p. 4.  
 41 
 
January 2015 developed licensing system of cannabis cultivation and possession for 
research purposes131. The first two educational institutions that obtained the permits 
were University of Washington and Washington State University. House Bill 2136132, 
however, deals with the cannabis taxation regulation. Originally, the effective cannabis 
tax rate consisted of several positions that summed up in total of 44%133. The new 
regulation diminished the total tax rate and combine producer, processor and retailer tax 
into tax of 37%, which is paid by the retail customer. The changes in taxation were 
maid due to the fact that the previous structure hindered retailers from claiming the tax 
as business expenditure. The medical cannabis patients receive sales and tax 
exemptions. The tax revenue must also be shared with the local municipality similarly as 
it is done by the alcohol tax. Additionally, the state has introduced following fees 
applicable to the cannabis transactions: 
 application fee for producer, processor and vendor - $250 each; 
 annual fee issuance and renewal for producer, processor and vendor - $1.000 
each; 
 administrative fees for change of location or proprietorship - $75 each134. 
2.4.2 An insight into economic aspects 
The actual purchase of recreational cannabis in Washington started in June 2014 and in 
the first month the sales reached $3.8 million and approx. $1 million in tax revenue135. 
In November 2014 tax revenues reached $0.24 million in local sales tax, $0.65 million in 
state B&O taxes and $0.65 million in state retail taxes, in total the cannabis tax revenue 
in November 2014 reached $1.5 million (this tax income is additional to the excise tax 
income)136. In period from January 1, 2014 to June 30, 2015 the cannabis sales reached 
                                           
131  State of Washington. Senate Bill 5121, 2015. Available on: 
http://lawfilesext.leg.wa.gov/biennium/2015-16/Pdf/Bil ls/Senate%20Bills/5121.pdf . 
Accessed in April 18, 2016.  
132  State of Washington. State Bil l 2136, 2015. Available on:  
http://lawfilesext.leg.wa.gov/biennium/2015-
16/Pdf/Bills/House%20Passed%20Legislature/2136-S2.PL.pdf. Accessed in April 18, 
2016.  
133  J. Henchman, “Taxing Marijuana: The Washington and Colorado Experience”. 
Tax Foundation, 2014. Available on: 
http://taxfoundation.org/sites/taxfoundation.org/files/docs/FF437.pdf . Accessed in 
April 18, 2016.  
134 Commonwealth of Massachussetts. Report of the Special Senate Committee on 
Marijuana, 2016. Available on: 
http://www.telegram.com/assets/pdf/WT1817038.PDF. Accessed in June 7, 2017. 
135 Supra note 132, p. 4.  
136  State of Washington, Department of Revenue. Available on: 
http://dor.wa.gov/content/home/. Accessed in April 18, 2016.  
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$259.5 million and the total tax revenue increased to $64.9 million 137 . This is an 
enormous increase compared to the first months of legal cannabis sale data.  
Currently there are 317 licensed vendor places statewide and average daily sales 
reach $2.9 million. Moreover, in fiscal year 2015 the total sales were estimated $259.8 
million, from which the tax income reached $64.9 million. The forecast calculation of 
2016 reveals that the total sales volume will reach $702.9 million and tax income will be 
$134.8 million. In the Image 4 there is given data with total sales and tax income 
monthly. The volume of sales is increasing every month and the forecasted data is 
believed to reach even higher volume of sales.  
2.4.3 Prevalence 
Washington State Health Youth Survey (WSHYS) data in period 2006-2012 revealed no 
significant change in cannabis use among students in 6th to 10th grade. The situation 
however was different for 12th graders, where the consumption of cannabis was 
increased by 4% in period 2006-2012138. The newest data from National Survey on Drug 
Use shows that in period 2012-2013 in Washington on average 9.81% of adolescents 
aged 12 to 17 had consumed cannabis in the past month and in period 2013-2014 this 
number was estimated to be 10.06%. In comparison, across the U.S. the average youth 
share that had used cannabis in the past month was 7.22%139.  
Substance Abuse and Mental Health Service Administration (SAMHSA) data 
reveals comprehensive 12-year observation of cannabis use tendencies in across the 
U.S. and in the states separately (see Appendix 4). From these data we can observe 
that, even though the cannabis consumption in Washington has been higher than the 
average of the U.S. data, the prevalence of cannabis among youth has not changed 
significantly before the legalization of cannabis and after. For example, cannabis past 
year consumption was 17.64% among 12-17 year olds in 2002-2003, however, in 2013-
2014 the consumption has even slightly diminished to 17.53%. First use of cannabis 
among 12-17 year olds has also declined from 7.14% in 2002-2003 to 6.7% in 2013-
20114. In other words, the main goal of children and youth prevention measures against 
the cannabis early consumption has been successful fulfilled, even though the legislative 
system has become more flexible regarding the prohibitive cannabis control mechanism. 
In the adult cannabis use the trends have not changed significantly. The only exception 
is the age group of 45 to 64, where the increase of past month use of cannabis changed 
form 4% in 2011 to 7% in 2013, which equals to 33% annual rise140.  
                                           
137  Washington State Liquor and Cannabis Board. Marijuana Sales A ctivity, fiscal 
year 2015. Available on: http://www.liq.wa.gov/records/frequently -requested-lists. 
Accessed in April 18, 2016.  
138  Washington State Department of Health. WSHYS Reports. Available on: 
http://www.doh.wa.gov/DataandStatisticalReports/DataSystems/HealthyYouthSurve
y/Reports. Accessed in April 19, 2016.  
139 Supra note 111.  
140 Ibid. 
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Image 4. Source: Washington State Liquor and Cannabis Board  
http://lcb.wa.gov/printpdf/marj/dashboard.  
2.4.4 Prevention 
The state of Washington had to accept the same federal level criteria in fight with 
cannabis as the state of Colorado and, additionally, it established its own prevention 
mechanism.  
The largest share of preventative measures funding is planned to be financed 
from the cannabis tax income. The main state institution responsible for the 
coordination of the measures is Washington State Department of Health (WSDH). When 
cannabis was legalized by Initiative 502 in 2012 the WSDH developed its implementation 
plan141. The first funding form the state’s government was received in 2015 and in total 
for the period 2015-2017 the funding was expected to reach $19 million. In accordance 
with the preventative and informative campaign program the WSDH in cooperation with 
Department of Social Health Services (DSHS) developed Community Grant Program for 
                                           
141  Washington State Department of Health. Initative 502 Implementation Plan 
(draft). Available on: 
http://www.theathenaforum.org/sites/default/files/DBHR_implementation%20for%2
0initiative%20502%20mandates_Final.pdf . Accessed in June 7, 2017. 
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educational institutions with high risk of cannabis abuse. This program gives opportunity 
to apply for grants intended to adoption of informative campaigns and prevention 
programs related to drug free extra curriculum activities and other alternative activities. 
Another goal is to created comprehensive media campaign. The target audience is set to 
be youth in age of 12-20, parents, and pregnant/breastfeeding mothers. The main 
campaign message is to encourage open discussions about cannabis and to promote 
health and active lifestyle choices.  
In general, the institutions of Washington have carried out the necessary 
preventative measures to assure that the public health system faces possible low harm 
level of the new drug policy. They specially focus on youth and it related informative 
campaigns to ensure that young people do not jeopardize their health. 
2.4.5 Cannabis policy advantages in state of Washington 
As mentioned before, the state of Washington supports and encourages 
cannabis, it related products and their potential therapeutic value further research. The 
Senate Bill 5121, adopted in March 2015, clearly states that special permits are available 
for: 
 testing cannabis, its structure and potency; 
 research of further cannabis therapeutic qualities and potential use in medicine; 
 research on most effective and well-considerate administrative measures 
regarding cannabis; 
 research on potential genome or agricultural use142. 
Regarding the issue of complex THC presence examination in the blood of suspicious 
drivers, state’s investment in research is already successful because the Washington 
State University is close to inventing cannabis breathalyzer, which in the future could be 
used to catch individuals driving under cannabis influence. As the Washington State 
University Chemistry Professor Herb Hill said about the development of such 
breathalyzer: “It’s taken years, but the goal is in sight”143. 
Similarly to the state of Colorado experience, also in Washington the cannabis 
related crime rates have dropped significantly. The crime rates are decreased almost in 
all crime categories and the cannabis legalization has not had a negative impact on 
overall crime situation in the state144. The related factor of the decrease in crime is the 
reallocation of police forces to more serious and global issues like hard drug, violent 
crimes, homicide crimes and organized crime/street gangs.  
                                           
142 Supra note 131, Section 1. Accessed in April 19, 2016.  
143 Washington State University. Marijuan Breathalyzer Under Development to Nab 
Drivers Taking the “High” road , 2015. Available on: 
https://news.cas.wsu.edu/2015/12/02/marijuana-breathalyzer-under-development-
to-nab-drivers-taking-the-high-road/. Accessed in April 20, 2016.  
144  Washington Association of Sheriffs and Police Chiefs. Crime in Washington, 
2014. Available on: http://www.waspc.org/assets/CJIS/ciw%202014%20small.pdf . 
Accessed in April 22, 2016.  
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2.4.6 Cannabis policy loopholes and issues 
In the state of Washington the traffic fatalities in general have been declining in the 
time period 2003-2013. The traffic fatalities, involved driver under influence of cannabis 
in combination with other intoxicating substances has also decreased annually by 
approx. 4% from 27% in 2004 to 15% in 2013145. Moreover, the amount of individuals 
driving under cannabis influence and involved in traffic fatalities has dwindled form 7% 
in 2004 to 2% in 2013146. Nevertheless, more recent data prepared by the Washington 
Traffic Safety Commission revealed that in 2014 trend of driving under any kind of 
cannabis influence has increased and fatality occurrences have increased from 33 in 
2013 to 76 in 2014. Drivers caught under only THC influence have been registered in 25 
occasions (comparing 12 in 2012) 147 . The traffic fatality data requires further 
observations in order to be able to forecast the actual trend.  
Due to the constrictions between state’s and federal cannabis legislation the 
state has to fulfill federal obligations in many areas, such as Food and Drug 
Administration, which is normally carried out by the U.S. Department of Agriculture. 
Another crucial aspect regarding cannabis industry is its relationship with banking 
system. On the one hand, cannabis is federally illicit drug and banks are prohibited to 
finance it related products and transactions. On the other hand, in several states, 
including Washington, cannabis is legal and should have ordinary financial relations with 
banks. The situation is resulting in basically cash-based transactions that are poorly 
controlled and regulated. Nevertheless, the state of Washington has developed smaller 
system of credit unions, although, the transactions are limited to the production level 
and the retail sales have still remained cash-based. 
  
                                           
145  Forecasting and Research Division, Washington State Office of Financial 
Management. Monitoring Impacts of Recreational Marijuana Legalization, 2015 . 
Available on: http://www.ofm.wa.gov/reports/marijuana_impacts_2015.pdf . 
Accessed in April 19, 2016.   
146 Ibid. 
147  Washington Traffic Safety Commission. Driver toxicology Testing and the 
Involvment of Marijuana in Fata l Crashes, 2010-2014, p. 47. Available on: 
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III ANALYSIS AND COMPARISON OF CANNABIS POLICIES 
IN THE NETHERLANDS, COLORADO AND WASHINGTON 
The Netherlands cannabis related policy is very different from the policies that are 
functioning in the U.S. states of Colorado and Washington. The Dutch attitude towards 
the respective substance is in many ways ambidextrous and cannot be regarded as legal 
cannabis market. This policy has many loopholes and does not solve cannabis related 
issues such as, organized crime and trafficking, harm to public/youth health, drug 
tourism and others, therefore in the analysis part the author will focus on comparison of 
Colorado and Washington cannabis policies and only occasionally mention Dutch 
example.  
Cannabis regulation started with development of comprehensive legal 
framework. The legislative outline was meant to cover all cannabis related issues and 
properly regulate it related transactions. First common feature of both legislations was 
to create market where cannabis for medical and recreational purposes would co-exist. 
Both states had already history with decriminalized and legalized medical cannabis 
regulations, which was complemented with different requirements for retail cannabis 
consumers. This dual policy in a large extent contributed to the expansion of the grey 
market. This market uses less regulated medical cannabis policy gaps to produce half-
legal output. In Colorado case the flexible definition of “caregiver” and poorly regulated 
home growing create suitable environment for the grey market. Moreover, the “grey” 
share of the market creates even greater danger to the existing system because of its 
uncontrolled nature (high THC potency, unknown fertilizers and other added substances, 
etc.). In order to be able to obtain medical cannabis, the individual is obligated to own 
medical card, which has to be renewed annually. This leads patients to a dilemma - to 
buy recreational cannabis to avoid the annual renewal of the permit or to buy medical 
cannabis in order to receive lower price (due to the lower tax rate).  
The state of Washington, on the other hand, has started to combine both 
markets. The goal is to develop more transparent regulatory structure and, for instance, 
force medical cannabis distribution centers to get licensed and under tougher control. 
Another important difference between both policies is that in Colorado home cultivation 
of cannabis is allowed but in Washington it remains illicit. In this way Washington strives 
to maintain the cannabis cultivation and production transparent to the local authorities. 
In comparison with the Colorado policy, Washington model would most probably create 
more homogeneous market with, therefore, more effective control mechanism. In 
addition, as the grey market would fade, the cannabis tax revenue would significantly 
increase.  
Regarding cannabis distribution, sales and the types of products allowed, there 
are several differences between Colorado and Washington. The state of Colorado has 
allowed selling all types of cannabis products, including edibles in different variations 
starting from cookies to candies. For instance, in 2014 in total 4.81 million units of 
medical and recreational cannabis edibles were sold in Colorado. This fact causes doubts 
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about edible cannabis products actual harm, because, first, it is harder to estimate the 
dosage of such cookie or candy and second, its appearance is much more attractive to 
the youth. Colorado now is willing to set the maximum dosage per serving, however, 
home cooked edibles are still under no control. In Washington edibles are also allowed 
only with exception of products appealing to the children.  
Another important aspect of cannabis policy is its regulation of THC potency. In 
the concentrates, which are legal in both, Colorado and Washington, the potency can 
reach THC of approx. 95% but cannabis plant itself can only reach THC level of about 
30%. Research carried out by research lab in Denver “CHARAS Scientific” revealed that 
the average potency of retail cannabis in Colorado is 18.5%, some samples even 
reached 30% potency of THC. In comparison, the Dutch cannabis policy limits THC 
potency to maximum 15%, which is significantly lower than in Colorado and 
Washington.  
Both states along with the Netherlands have strictly limited the commercialization 
of cannabis industry. This has been done taking into account the previous experience 
with the tobacco market and failures of its restriction. In the Netherlands all kinds of 
promotion, advertising and commercial activities are prohibited. To restrict the 
commercialization of cannabis market Colorado and Washington are applying different 
approaches to avoid vertical integration. Colorado policy allows multiple vendor, 
producer, grower “several links of the chain” system (see Amendment 64). However, 
Washington policy allows only vendor to hold simultaneously producer, processor and 
retail licenses (see Initiative 502). In other words Colorado is willing to diversify the 
cannabis market and does not want to allow developing of monopolies. The state of 
Washington, alternatively, is willing to keep cannabis market controllably small and does 
not want to allow the cannabis industry to become fragmented. Both approaches are 
different and at the moment it is very difficult to forecast which of those two methods 
will be more successful.  
In general, cannabis market is structured similarly as it is done by the alcohol 
market. For instance, cannabis and it related products are sold in separate places 
(vendor stores) and no other products are allowed to be sold there. Washington has also 
limited the statewide amount of cannabis stores to 334 - one store per 20.000 
people) 148 . Washington has gone another step ahead and has developed special 
licensing mechanism and regulations on particular locations, including density and 
distance from the schools and other adolescent attended places149. For instance, the 
retail place is not allowed to be allocated within 1.000 feet (approx. 300 m) of schools, 
parks, libraries and other locations. In comparison, Colorado does not strictly regulate 
the density of the cannabis vendor stores.  
                                           
148 Supra note 123.  
149 Canadian Centre of Substance Abuse. Cannabis regulation: Lessons learned  in 
Colorado and Washington State, 2015. Available on: 
http://www.ccsa.ca/Resource%20Library/CCSA-Cannabis-Regulation-Lessons-
Learned-Report-2015-en.pdf. Accessed in Apri l 20, 2016.  
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 The least transparent taxation system and revenue utilization was observed in 
the Netherlands. The country does not make cannabis related data available to public 
and also has no clear policy how to use the income from the cannabis industry. Colorado 
and Washington on the other hand, do supply public with the information about the 
cannabis tax revenues and the plan how to use them. Both states have implemented 
their tax system based on the sales price, which is not always the most accurate 
approach. All the taxes by their nature are listed in the Table 3 below.  
 
 Colorado Washington 
Tax base Price, in some occasions 
weight 
Price 
Tax type Excise and sales tax Sales tax 
Excise tax rate 15% - 
Cannabis specific 
tax rate 
10% 37% 
General state 
sales tax rate 
2.9% 6.5% 
Optional tax rate Determined by the local 
government 
Determined by the local 
government 
Other fees (Renewed) licensing, 
cultivation, distributer, 
vendor fees 
(Renewed) licensing, 
cultivation, distributer, 
vendor fees 
(Renewed) licensing 
Table 3.  
Additionally, as it is mentioned earlier in the text (part 2.3 and 2.4), both States have 
their own unique fee system. In comparison, the state of Washington has developed 
more concise system with less detailed structure. The state of Colorado, in contrast, has 
introduced complex and very detail-extensive mechanism of applicable fees. 
Taking into consideration all the tax and fee requirements, we can observe that 
Washington in total has higher tax burden, however, Colorado has more massive fee 
system. Nevertheless, in the time period of July 1, 2014 to June 30, 2015 Colorado 
earned $87 million in tax income contrary to Washington, which in the same period 
earned $75 million. These data show that either the tax revenue system is less efficient 
in Washington or that there still exists a large proportion of the black market production. 
Truth to be told, the future earnings forecast are more optimistic for the state of 
Washington. If the cannabis demand is continuing to increase in similar pace as it is 
observed up to now (parts 2.3.3 and 2.4.3), Colorado could earn $125 million and 
Washington $163 million in the current fiscal year. 
Generally, the cannabis industry relationship with banking sector is not very well 
developed and has many issues. Banks along with the largest credit card companies Visa 
and MasterCard are unwilling to participate in cannabis related transactions due to their 
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impenetrability and reputation of being in the grey zone of economy. However, some 
smaller banks have agreed to cooperate while also fulfilling the state requirements of 
due diligence and compliance reporting. If we compare the cannabis industry banking 
experience in all three locations, the least satisfactory situation is in the Netherlands. As 
cannabis and it related products are illicit under the official law, banking institutions are 
prohibited to have any transactions with coffee shops. In other words, the cannabis 
market is based only on cash related transactions, which are difficult to track and 
control, especially, regarding the origin of money. The consequences are that cannabis 
market is place where organized crime can carry out money laundering, illicit trafficking 
and other black and grey market related transactions.  
In contrast, Colorado and Washington have chosen more transparent and 
accessible cannabis related banking model. At federal level the development of Bank 
Secrecy Act150  was turning point in banking relations with the cannabis business. It 
allows banks to cooperate with cannabis businesses without breaking the federal law. 
However, in exchange the banks are required to ensure that the cannabis business 
complies with the federal law. At state level Colorado and Washington have introduced 
their own financial system. There are three domestic banks and one credit union that 
maintain the approx. 70% of the cannabis business in Colorado. The state of 
Washington has also encouraged several credit unions to cooperate with cannabis 
industry in order to ensure more transparent and controllable business environment.  
3.1 Possible improvements of the existing legal control 
framework 
First of all it is crucial that the international organizations and national governments 
admit that existing control framework is not working properly and the desirable outcome 
of “drug-free” world is still far from the real situation. However, the changes in the legal 
regulatory outlines have to be well considerate and made step by step. 
3.1.1 Measures recommended before the actual change of legislation 
At the beginning, the UN and national government should start public discussions with 
the aim to find out how well educated is the society and what is the overall attitude 
towards cannabis. It is important to understand the position of the society before 
proposing any suggestions. 
Before the actual changes in legislation, preventative measures should be carried 
out both at national and international level. In other words, the informative campaigns 
and different policy mix should be effective enough to educate people and reduce the 
consumption of recreational substances. Special attention should be drawn to the 
                                           
150 FinCEN. Guiding Principles for Anti -Money Laundering Policies and Procedures in 
Correspondent Banking, 2014. Available on: http://www.fatf-
gafi.org/media/fatf/documents/reports/Guidance-Correspondent-Banking-
Services.pdf. Accessed in June 7, 2017. 
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younger generation - schools, where cannabis is used particularly often. A survey of 
2014 carried out by the University of Michigan revealed that 11.7% of 8th graders and 
35.1% of 12th graders have tried cannabis or hashish. These data shows that cannabis is 
the absolute leader in the area, completely overpowering such substances as 
hallucinogens, ecstasy and cocaine151. Also in the EU the typical cannabis user audience 
is school students. Surveys in 2011 showed that lifetime cannabis use among 15-16-
year-old pupils spanned from 5% in Norway to 42% in Czech Republic152. 
The international society should invest more in the research of cannabis and its 
potential therapeutic value in order to use its full range of qualities. The scientific proof 
should be carried out possibly independent and should be announced publicly to inform 
society about the recently discovered features of cannabis and possibilities to use them 
for health improvement necessities.  The science and research based approach is 
essential to build evidence based law system and regulatory mechanism. Another 
important aspect is to consider already legally existing alcohol and tobacco market 
regulations and learn from their experience and failures. The cannabis market should be 
kept limited in order to avoid its over-commercialization and excessive expansion.  
The drug policies must also be developed in conformity with the international 
human rights standard. First of all, countries should distinguish people at the lower level 
of cultivation, distribution and possession from those who are managing large-scale 
production and distribution. The first-time, small-scale growers and users should be 
treated less punitive than, for instance, the organized crime groups and traffickers. In 
this way countries could transform their harsh penal systems into more civil and, in 
truth, much more needed systems for the society prosperity. The transition to this kind 
of system would also take the pressure off the prison system. The EMCDDA research on 
estimation of public expenditure on drug-law offenders in prisons revealed that in 2010 
the Europe on average 18.5% of all sentenced prisoners were drug-law offenders153. As 
more than a half of the drug-law offences are linked to transactions with cannabis and 
the average spending on drug-law offenders in European prisons (in 2010) reached 
approx. 0.08% of total public expenditure154 , we can estimate that the total public 
expenditure on different cannabis related offences in the European countries reached 
0.04%. If cannabis regulatory system were being changed, the overcrowded European 
prison system would be relieved and the related governmental investment could be used 
                                           
151 National Institute on Drug Abuse: High school and youth trends. Available on: 
https://www.drugabuse.gov/sites/default/fi les/high_school_and_youth_trends_dece
mber_2014.pdf. Accessed in March 31, 2016.  
152  European Monitoring Centre for Drugs and Drug Addictions. Cannabis drug 
profile/Prevalence. Available on: http://www.emcdda.europa.eu/publications/drug-
profiles/cannabis#prevalence. Accessed in March 31, 2016.  
153 European Monitoring Centre for Drugs and Drug Addictions. “Estimating Public 
Expenditure on Drug-Law Offenders in Prison in Europe”, 2012. Available on: 
http://www.emcdda.europa.eu/system/files/publications/783/TDAU13007ENN_4627
78.pdf. Accessed in Mach 31, 2016.  
154 Ibid.  
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for preventative campaigns and improvement of rehabilitation treatments and facilities. 
Moreover, people with health and pain history that are caught using cannabis should be 
treated not as criminals but as patients. In addition, people with signs of cannabis 
addiction should be provided with access to the treatment and rehabilitation programs.  
The UN as an influential international organization should early identify the 
forthcoming changes in the public and scientific thinking and take responsibility to 
transform the transnational regulatory system regarding cannabis. The main challenge is 
to bring countries with different opinions to one table and start discussion of the 
changes necessary to adopt the existing law regime to the alternating situation. The UN 
should first, start rebuilding a new legal framework based on scientific discoveries. 
Second, it should encourage countries to follow their lead and also observe the 
progressing situations in the countries and territories where cannabis has already been 
introduced in national legal system as a legal, strictly regulated recreational substance.  
At national level the countries should develop an effective and well-considerate 
regulatory framework and administrative capacity to be able to control the system. 
There should be proactive investment in the health industry and in comprehensive 
informative campaigns targeting the risk audiences, especially adolescents. The 
enforcement has to be rigid and concrete, with no gaps and ambiguous interpretations. 
In order to be able to correct any loopholes and other falsehoods, the states should 
promote further research to establish proof of the genuine nature of cannabis. To 
analyze the effects of the cannabis legalization, the statistical data should be collected 
and evaluated on a regular basis.   
3.1.2 Regulatory law changes at international level  
In this part of the work the author will give more detailed explanation of possible legal 
step-by-step procedure how the new legal framework of changing cannabis status could 
be implemented both at international and national levels.  
As it is stated previously, the Single Convention (1961) places cannabis and it 
related mixtures among the most dangerous substances with no therapeutic value. In 
order to allow countries to change cannabis status at national levels in compliance with 
the international law, the UN has to replace cannabis to lower schedule or delete it form 
the Single Convention. The Single Convention, Article 3, paragraph 6 states that a 
substance, which is already included in the Schedule I can only be transferred to 
Schedule II or completely deleted from the list of restricted substances155. The first 
option to replace cannabis to Schedule II makes no sense, since it still prohibits the 
cultivation, production and sale of the respective substance. In a case of deleting 
cannabis from the Single Convention, the WHO should make a recommendation to CND 
and the CND would then by voting decide whether to keep or delete cannabis from the 
Schedule (majority vote needed). In recent decade the WHO has published several 
                                           
155 Supra note 3, Art. 3, para. 6.  
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reports with recommendations to reschedule cannabis156  to less stringent schedules, 
however, the CND has stayed reluctant and is not willing to replace the respective 
substance. Moreover, the WHO recommendation to reschedule dronabinol has been 
ignored by the CND in this way even more hindering the rescheduling of cannabis.  
Another option to change cannabis status would be to create new formal 
amendment to the existing three Convention framework. First, cannabis as regulated 
substance should be removed from the existing international drug control framework. 
Second, the scope of the existing Conventions should also be changed. As it is defined in 
the Single Convention, Article 47, paragraph 1 “any Party may propose an amendment 
to this Convention”157. In addition, the voting should take place during the UN ECOSOC 
meeting, where, in order to pass the amendment, all the Member States should vote 
unanimously. However, as mentioned before, the Member States have very different 
opinions about the cannabis policy, so it is improbable that such amendment would 
eventually be adopted.  
The last but not the least possible option is to create an exclusive convention for 
cannabis regulation. An example could be taken from the Framework Convention on 
Tobacco Control158. This convention offers Member States non-prohibitory approach to 
regulate both legal and illicit transactions related to tobacco. To avoid incompatibilities 
with the existing Conventions the cannabis treaty should include clause, which releases 
the contracting parties from any other prior obligations defined in the existing three 
Convention framework. The cannabis convention should set standards regarding 
cultivation, production, sale (trafficking) and consumption (possession) that each 
Member State could implement in this way creating globally harmonized cannabis 
regulatory law. The framework should be loose enough to comply with the national laws 
and stringent enough to ensure proper international control of cannabis. One of the key 
criterions for the development of cannabis Convention should be the scientific ground 
for all clauses. Outcomes of the legal regulation should be observed in annual reports 
and the results assessed by analyzing further development of cannabis policy - whether 
the legalization is working properly and, if not, what could be improved.  
3.1.3 Regulatory changes at national level 
In the existing international legal control mechanism of cannabis countries that are 
willing to change their policy towards the regulation of respective substance are facing 
several difficulties, for instance, they are bound to the international obligations. 
However, if they are willing to ease the control regime of cannabis at national level 
there are still several approaches available.  
                                           
156 Supra note 30.  
157 Supra note 3, Art. 47, para. 1.  
158  WHO Framework Convention on Tobacco Control, 2003. Available on: 
http://apps.who.int/ir is/bitstream/10665/42811/1/9241591013.pdf . Accessed in 
April 1, 2016.  
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First, there are so called “soft tools”. The Conventions, for example, leave 
Member States some freedom how to restrict actions related to cannabis. One option is 
decriminalization of cannabis, which is not prohibited under the international framework. 
Another option is already used in the Netherlands (coffee shops) and Spain (cannabis 
social clubs). The legal status of these institutions is rather unclear but, as it is observed 
already for many years, this kind of system works sufficiently well. Second, more and 
more popular become so called “hard tools”. This approach means that country openly 
breaches the UN three Convention framework by legalizing cannabis and opening 
regulated market of the respective substance to the public.  
Another even more drastic option for countries could be denunciation of the 
Conventions fallowed later by re-accession with a national reservation on cannabis. The 
country willing to reform cannabis policy could withdraw from the Single Convention 
along with 1988 Convention. Fallowing the denunciation the country could then re-
access to the Conventions with reservations regarding particular prohibition or restriction 
articles and clauses. In 2011 Bolivia decided to use this approach regarding coca leaf 
traditional use in the country. It first withdrew its membership of the 1961 Single 
Convention and its amendment of 1972 and then re-accessed to the respective Treaties 
with reservations regarding the use and cultivation of coca leaf. The INCB commented 
Bolivia’s decision with regret and emphasized, “while that course of action is technically 
permitted under the Convention, it is contrary to the fundamental object and spirit of 
the Convention” 159 . In the Bolivia’s case the main argument was that coca leaf is 
traditionally used for centuries in the country so it cannot be prohibited so easily. The 
term “traditional use” could also be linked to cannabis and its use in countries such as 
Morocco and Egypt, however, the term is legally not clear enough to apply this opting-
out option also to cannabis.  
Another “hard tool” option would be withdrawal of the Conventions. This 
approach, however, would be politically and diplomatically extremely difficult. It also 
would bring additional legal problems to the country because not only it withdraws its 
membership regarding cannabis restriction but also regarding any other drugs that are 
regulated in the Conventions. This option is unlikely to be used by any country because 
this approach creates more harm than benefit.  
So as we have seen from the previously mentioned options, none of them 
actually offers a decent solution to regulate cannabis in a reasonable manner, therefore, 
the author will observe several step-by-step options for drug law reform if the 
international legal framework was changed to more flexible model and allowed countries 
to develop an alternative cannabis control regime. 
First step - depenalization of cannabis. In other words, depenalization means 
that the government removes criminal penalties for simple, first-time, small-amount 
                                           
159  INCB Report, 2011, paragraph 279. Available on: 
https://www.incb.org/documents/Publications/AnnualReports/AR2011/AR_2011_Eng
lish.pdf. Accessed in April 1, 2016.  
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transactions with cannabis. Depenalization system, for instance, could be divided into 
several steps. Similar experimental scheme was carried out in the UK in 2004 and was 
called “Lambeth Cannabis Warning Scheme” (LCWS). The main principle was to 
distinguish small amount, first-time cannabis possessions form the organized drug 
dealers and organizations. Those who got caught first time for simple possession did not 
get criminal record or jail time. If caught second time the person got relatively small 
money fine but, if caught third time, the individual was arrested and received either 
caution or got prosecuted160. This trial leads to significant results that show drop in 
cannabis use161. 
Second step - de facto decriminalization. De facto decriminalization is the middle 
way between depenalization and decriminalization. The de facto decriminalization still 
means that cannabis is illegal under the national law, however, it does allow the 
possession of small amounts of the respective substance. However, this change of law 
leaves cannabis in the grey zone and does not allow the government to fulfill its control 
duty.  
Third step - de jure decriminalization. De jure decriminalization means that 
cannabis personal possession is no longer a criminal offence, yet it is still illegal. 
Decriminalization inheres remarkable advantage over de facto decriminalization because 
it is formalized in law and people caught for possession of small amounts of cannabis do 
not instantly get criminal record. For governments decriminalization still causes several 
challenges. The main of them is to create proper mechanism how to effectively 
distinguish personal use from possession for further external supply. One approach is to 
define the limit until which it is considered “for personal use”. Larger amount then is 
considered with purpose to supply other individuals. Another approach takes into 
account many other factors that usually are evaluated by police or court. Around 30 
countries have decriminalized cannabis worldwide (see Appendix 1).  
However, the model of decriminalization lacks several important aspects, for 
instance, content, origin and the volume of THC, which basically leaves the users 
without any knowledge of the substance they are using. Secondly, people with addiction 
problems cannot be effectively treated because the law prohibition of cannabis 
abnegates the necessary preventative measures to be effectively enforced. Thirdly, the 
decriminalization does not struggle with organized criminal organizations and traffickers. 
The criminal elements still expose people not only to cannabis but to other, more 
dangerous substances.  
                                           
160  European University Institute, Department of Economics. Crime and the 
depenalization of Cannabis Possession: Evidence From a Policing Experiment, 2014. 
Available on: 
http://cadmus.eui.eu/bitstream/handle/1814/31225/ECO2014_05.pdf?sequence=1. 
Assessed in April 4, 2016.  
161 Department of Health. United Kingdom Drug Situation 2011: p. 25. Available on: 
http://www.nta.nhs.uk/uploads/2011.pdf. Accessed in April 4, 2016.  
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Several countries have expressed an opinion that legalization of cannabis and its 
proper regulation would be another alternative in dealing with issues related to the 
respective substance. The Image 5 below graphically explains how the cannabis policy 
should be created in order to reach the best social results and reduce harm to the public 
health. Ultra prohibition and commercial promotion policy would have the same ill effect- 
in the first case the market would be fulfilled via unregulated criminal market and in the 
second case the demand would be satisfied by unregulated legal market, which would 
lead to market commercial lobbying and serious public health issues. The best approach, 
suggested by this paper, would be strict legal regulation. The concept of legal 
regulations could be perceived as straightforward but actually it is very complex 
mechanism with many variables and issues that have to be taken into consideration.  
3.1.4 Specifics of cannabis regulation 
Licensing. The model of licensing could be presented at different levels of the 
transactions related to cannabis. The licensing would include, first, the licensing of the 
cultivation and production of cannabis. The state should implement such mechanism 
that controls the potency of the cannabis plant and its resin. The THC level should be 
controlled through minimum and maximum content per gram of the substance. There 
also should be regulation for potentially soil contamination and fertilizers used in the 
cultivation. In order to ensure that several large companies do not control and lobby the 
market, the states should limit the production. Different types of cannabis should be 
easily distinguishable so they could be identified by dissimilar designations, for instance, 
the name, producer or category. In addition, countries should regularly control the 
licensed retailers to monitor the production system162. 
 
  
                                           
162 Transform Drug Policy Foundation. How to regulate Cannabis, a practical guide, 
2014. Available on: 
http://www.unodc.org/documents/ungass2016/Contributions/Civil/Transform-Drug-
Policy-Foundation/How-to-Regulate-Cannabis-Guide.pdf. Accessed in June 7, 2017. 
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Image 5. Source: ALICE RAP Policy Brief 5. Cannabis- from prohibition to regulation. 
3.1.4 Specifics of cannabis regulation  
Price control. While developing cannabis price policy it is important to take into 
consideration several important aspects. In order to eliminate the criminal black market 
the legal price should be equal or lower than the price for identical product sold on the 
illicit markets. This means that also tax rate should be applied adequate and 
proportional. There can be several bases for the approximation of tax rate but the 
widely used in the potency based approach.  The stronger is the substance, the higher 
tax rate is applicable. This method is already widely used in the alcohol market, which 
gives countries satisfactory results. However, there are other types of pricing that could 
be taken into consideration and used to establish the appropriate pricing mechanism: 
 direct price fixing - government fixes the price at which cannabis must be sold; 
 minimum/Maximum prices - policy that allows market certain level of flexibility; 
competition; 
 fixed per unit tax - approach that was mentioned above. Can be applied to 
substance amount, to the THC amount or to production/retail level; 
 percentage sales tax - percentage of a product’s sales price; 
 mixed approach - the State can mix the strategies and apply any other approach. 
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Moreover, taxation mechanism possible to apply to the cannabis price can be divided 
into several different groups. First, tax added to the sales value, which would then be 
easy administered by the governments. Second, the tax added to wholesale or to the 
producer (for instance, farm), which then would limit the risk of tax avoidance and 
would be easy to administer. Third, fixed tax rate per unit weight. This approach would 
also be easy to administer but would probably encourage sellers to offer stronger 
cannabis with higher level of THC, which consequently costs more. Fourth, tax added to 
the THC, which would be difficult to control but would deter producers from offering 
strong potency cannabis. The fifth approach would be to set progressive tax according 
to the level of THC or amount bought by the client. The last but not least approach 
would be license fees that would be issued to the licensed retailers and would be easy 
to control. 
Packaging control. The appropriate packaging is another important aspect of 
cannabis policy and its restriction. The packaging of cannabis should have adequate 
labeling with all the warning signs, units, validity and other signs necessary to provide 
consumer with full information about the product. Also the age restriction to access 
cannabis should be defined in the national law and the licensed retailers would have 
responsibility to control its clients using ID system.   
Advertising/promotion. The advertisement, similarly to tobacco and alcohol 
promotions, should be strictly limited. The cannabis products, in general, should be 
generic and without special brandings. The media advertisements should also be 
restricted and different promotions and event sponsoring, especially youth related, 
should be prohibited.  
Location/density of outlets. Location of the outlets and licensed stores should be 
strictly confined and placed distant from schools, universities and other similar places 
where it could be available to the youth. For instance, in the Netherlands coffee shop 
system is strictly defined to sell only cannabis and other substances like alcohol are 
strictly forbidden to sell at the same place163.  
  
                                           
163  Transform Drug Policy Foundation. After the War on Drugs: Blue print for 
Regulation. Available on: http://www.tdpf.org.uk/sites/default/files/Blueprint.pdf  
Accessed in April 6, 2016.  
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CONCLUSION 
The main goal of this article was to prove the need for changes in the attitude towards 
cannabis, its legal regulation and possible economic benefit.  
In the first part of the work the author concludes that the existing international 
UN Drug Conventions are failing to ensure the homogeneity of the transnational 
cannabis policy and are actually obstructing the international society from the in-depth 
research of the respective substance that could possibly lead to the changes in the 
cannabis related legislation. If there are researches carried out regarding the respective 
substance (especially if they are in favor of it) the UN institutions are most likely to 
ignore them, even if the reports and data are published by such widely respected 
organization as WHO. Moreover, the existing international legal regulation of cannabis is 
inconsistent with the human rights and does not fulfill its initial aim- to avoid the 
prevalence of cannabis use and its ill impact on public health. In addition, the author 
finds out that several researches have proven the actual harmful effect of the respective 
substance to be exaggerated and it is, in fact, less noxious than the influence, for 
instance, of tobacco. 
In the second part the author reveals advantages and loopholes of the three 
more liberal cannabis policies in the Netherlands, Colorado and Washington. First, it 
revealed the lack of control over the coffee shops in the Netherlands. Since this business 
is mainly cash-based, the transactions are not transparent, the state does not earn the 
potential amount of tax income and the cannabis market becomes vulnerable to criminal 
organization and money laundering. Moreover, the discrepancy between cannabis supply 
and demand suggests that the black market still has a significant share of the Dutch 
cannabis market. In addition, the public health issues regarding cannabis are also not 
sufficiently controlled and there is lack of the data about the actual situations in all 
cannabis related areas. 
In the next part the author reveals the advantages and loopholes of the cannabis 
policies in the U.S. states of Colorado and Washington. In Colorado the state has 
created very detailed and robust cannabis control regime. It has developed effective 
licensing and taxation system, from which the income is devoted mostly to the health 
and education fields. The domestic institutions also cooperate with the federal level 
institutions and have created comprehensive mechanism of preventative measures, 
especially regarding the adolescents.  
The main loopholes of the Colorado cannabis policy are the failure to control the 
home growing, medical cannabis market and deficient management of banking system 
collaboration with the cannabis retailers. Moreover, the legislation is diffused and vague 
regarding the term “caregivers” and allows speculations with law and it requirements.  
In the state of Washington the fee and tax system is less detailed that in 
Colorado and, up to now, this approach has given the state less income than in 
Colorado. However, there are also other affecting factors and the data have been 
collected only over three year span so the situation could change easily. Nevertheless, 
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Washington has more stringed requirements regarding other specifics of cannabis policy, 
such as the density of the vendor stores, the promotion and labeling of the cannabis 
related products. In addition, Washington invests much of their funds in cannabis 
research that could give positive outcome in the future.  
Similarly to Colorado, Washington lacks effective banking sector and cannabis 
industry cooperation.  This issue, however, is attempted to be solved at federal level and 
is believed to be successful in the future. Another disadvantage of the cannabis policy is 
its involvement in the driving fatalities, which have increased after the legalization of the 
respective substance.  
In the last concluding part of the analysis the author first, discusses how the 
existing legal framework could be improved and what steps should be taken before any 
regulatory changes regarding cannabis have been started. For the UN and national 
governments it is recommended to start public discussion about the respective topic 
and, in order to develop the most adequate control mechanism, it is also advised that 
the regulatory changes should be carried out based on the scientific proof and research. 
Moreover, the cannabis control mechanism should be changed in a way that it would be 
in conformity with the international human rights. The author also shows that the only 
possible way to limit and truly control cannabis market is to legalize it and expose the 
respective substance to robust and strict control mechanism.  
Regarding the changes in national cannabis legislations, the author distinguishes 
three main steps. The first is depenalization of the respective substance, which would 
ease punishment for small-scale drug transactions. Second step is de facto 
decriminalization, meaning that cannabis would stay illegal but small transactions with it 
would be allowed. This approach, in fact, is not the best solution for cannabis related 
problems because it creates many grey zones in the industry. Third step is de jure 
decriminalization when the transactions with cannabis are no longer criminally punished, 
yet the respective substance still remains illegal.  This approach also has its 
disadvantages, such as incomplete control mechanism regarding, for instance, the origin 
and the level of THC in the cannabis production. Taking into consideration all the 
previously discussed aspects, the author suggests that the best approach would be the 
legalization and strict regulation of cannabis market. In the regime of cannabis 
legalization the domestic jurisdictions should implement several criteria to control the 
demand and supply of the respective substance. Such criteria should include 
requirements related to price control, licensing, packaging, advertisement and 
promotion, location and density limitations.  
Overall, the author concludes that the UN international drug conventions are not 
effective enough and should be improved based on the latest scientific data. The 
countries should observe the jurisdictions with more liberal cannabis policy, the progress 
and shortages of their performance and decide whether to make corrections in their 
domestic legislation or not. In the end, the UN and it Member States should come to one 
table and discuss the future prospective of the cannabis policy.  
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Appendix 1: Legal status of cannabis in world countries 
Country Production Sale  Trafficking Possession Notes 
Albania Illegal Illegal Illegal Illegal Often "soft” 
interpretation 
of 
Algeria Illegal Illegal Illegal Illegal   
Argentina Illegal Illegal Illegal Decriminalized 
for small 
amounts, 
personal use 
Tolerant 
society 
attitude 
Australia Illegal Illegal Illegal Illegal But 
decriminalized 
in Australian 
capital 
territory, 
South 
Australia & 
Northern 
territory 
Austria Illegal Illegal Illegal Decriminalized 
(≤5g) 
  
Bangladesh Illegal Illegal Illegal Illegal No sufficient 
laws 
Belgium Decriminalized 
1 plant 
Illegal Illegal Decriminalized 
(≤3g) 
  
Belize Illegal Illegal Illegal Illegal Tolerant 
society 
attitude 
Bolivia Illegal Illegal Illegal Decriminalized   
Botswana Illegal Illegal Illegal Illegal No sufficient 
laws 
Brazil Illegal Illegal Illegal Illegal   
Bosnia& 
Herzegovina 
Illegal Illegal Illegal Illegal   
Belarus Illegal Illegal Illegal Illegal   
Bulgaria Illegal Illegal Illegal Illegal   
Cambodia Decriminalized Decriminalized Decriminalized Decriminalized Tolerant 
society 
attitude 
Canada Legal 
(medical) 
Legal 
(medical) 
Illegal Legal 
(medical) 
Changes in 
2015 
Chile  Legal (small 
amounts 
Decriminalized 
(medical) 
Illegal Decriminalized   
China Illegal Illegal Illegal Illegal   
Columbia Legal (≤20 
plants) 
Legal 
(medical) 
Legal 
(medical) 
Legal(≤22g)   
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Costa Rica Decriminalized Illegal Illegal Decriminalized Tolerant 
society 
attitude 
Croatia Illegal Decriminalized 
(medical) 
Illegal Decriminalized   
Cyprus Decriminalized 
(for restricted 
amount of 
farms) 
Illegal Illegal Illegal   
Czech Rep. Decriminalized 
(≤5 plants) 
Decriminalized 
(medical, 
≤15g) 
Decriminalized 
(medical, 
≤15g) 
Decriminalized 
(≤15g) 
Decriminalized 
for personal 
use 
Denmark Illegal Illegal Illegal Illegal Exception-
Freetown 
Christiania 
Dominica Illegal Illegal Illegal Illegal   
Ecuador Illegal Illegal Illegal Decriminalized 
(≤10g) 
  
Egypt Illegal Illegal Illegal Illegal Often used 
though 
Estonia Illegal Illegal Illegal Decriminalized 
(≤7.5g) 
  
Ethiopia Illegal Illegal Illegal Illegal   
Finland Illegal Illegal Illegal Illegal   
France Illegal Illegal Illegal Illegal   
Germany Legal under 
permission, 
for medical 
use 
Legal under 
permission, 
for medical 
use 
Legal under 
permission, for 
medical use 
Legal under 
permission, for 
medical use 
Possession 
illegal, use 
legal. Most 
tolerant - 
Berlin 
Greece Illegal Illegal Illegal Decriminalized 
(≤2 joints) 
  
Honduras Illegal Illegal Illegal Illegal   
Hong Kong Illegal Illegal Illegal Illegal   
Hungary Illegal Illegal Illegal Illegal   
Iceland Illegal Illegal Illegal Illegal   
Indonesia Illegal Illegal Illegal Illegal   
India Illegal Illegal Illegal Illegal Tolerant 
society 
attitude 
Ireland Illegal Illegal Illegal Illegal Government 
policy to 
decriminalize 
in future 
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Israel Illegal Illegal Illegal Illegal For medical 
purposes legal 
possession, 
sale, 
trafficking 
Italy Illegal Illegal Illegal Decriminalized 
(medical) 
  
Jamaica Legal (for 
personal use, 
≤5 plants) 
Illegal Illegal Decriminalized 
(≤2oz) 
  
Japan Illegal Illegal Illegal Illegal   
Jordan Decriminalized Illegal Illegal Decriminalized First Arab 
state to 
decriminalized 
Laos Illegal Illegal Illegal Illegal   
Latvia Illegal Illegal Illegal Illegal   
Lebanon Illegal Illegal Illegal Illegal   
Lithuania Illegal Illegal Illegal Illegal   
Luxembourg Illegal Illegal Illegal Illegal   
Macedonia Illegal Illegal Illegal Illegal   
Malaysia Illegal Illegal Illegal Illegal   
Malta Illegal Illegal Illegal Decriminalized 
(≤3.5g) 
  
Mexico Decriminalized Illegal Illegal Decriminalized 
(for personal 
use, ≤5g) 
  
Montenegro Illegal Illegal Illegal Illegal   
Nepal Illegal Illegal Illegal Illegal   
Netherlands Decriminalized 
(≤5 plants) 
Legal for 
coffee shops 
Illegal 
(unenforced 
for coffee 
shops 
Legal (≤5g) Coffee shop 
system 
New Zealand Illegal Illegal Illegal Illegal   
North Korea Illegal Illegal Illegal Illegal   
Norway Illegal Illegal Illegal Illegal   
Pakistan Illegal Illegal Illegal Illegal   
Panama Illegal Illegal Illegal Illegal   
Paraguay Illegal Illegal Illegal Decriminalized 
(≤10g) 
  
Peru Illegal Illegal Illegal Decriminalized 
(≤8g) 
  
Philippines Illegal Illegal Illegal Illegal   
Poland Illegal Illegal Illegal Illegal   
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Portugal Decriminalized Illegal Decriminalized Decriminalized in 2001 first 
country that 
decriminalized 
use of all 
drugs 
Puerto Rico Illegal Illegal Illegal Illegal Legal for 
medical use 
Romania Illegal Illegal Illegal Illegal   
Russia Decriminalized 
(≤20 plants) 
Illegal Decriminalized 
(≤6g) 
Decriminalized 
(≤6g) 
  
Saudi Arabia Illegal Illegal Illegal Illegal   
Serbia Illegal Illegal Illegal Illegal For medical 
use 
possession 
and sale legal 
Singapore Illegal Illegal Illegal Illegal   
Slovakia Illegal Illegal Illegal Illegal   
Slovenia Legal if 
(THC≤0.2% 
on ≤0.1 ha 
surface) 
Illegal Illegal Decriminalized   
South Africa Illegal Illegal Illegal Illegal   
South Korea Illegal Illegal Illegal Illegal   
Spain Legal, for 
personal 
consumption 
Illegal Decriminalized Legal for 
personal 
consumption, 
private areas 
Legal 
possession 
and 
production if 
not in public 
Sri Lanka Illegal Illegal Illegal Illegal Widely used 
though 
Sweden Illegal Illegal Illegal Illegal   
Switzerland Legal in 
private 
property 
Illegal Illegal Decriminalized   
Syria Illegal Illegal Illegal Illegal   
Taiwan Illegal Illegal Illegal Illegal   
Thailand Illegal Illegal Illegal Illegal   
Tunisia Illegal Illegal Illegal Illegal   
Turkey Illegal Illegal Illegal Illegal   
Ukraine Decriminalized 
(≤10 plants) 
Illegal Decriminalized 
(≤5g) 
Decriminalized 
(≤5g) 
  
UAE Illegal Illegal Illegal Illegal   
UK Illegal Illegal Illegal Illegal   
 64 
 
USA Illegal Illegal Illegal Illegal Legal in 
Colorado, 
Washington, 
Oregon, 
Alaska, cities 
of Portland, 
South 
Portland 
Maine, 
Washington 
D.C. 
Decriminalized 
in 18 states, 
medically legal 
in 25 states 
Uruguay Legal Legal Legal Legal   
Uzbekistan Illegal Illegal Illegal Illegal   
Venezuela Illegal Illegal Illegal Illegal   
Vietnam Illegal Illegal Illegal Illegal   
Zimbabwe Illegal Illegal Illegal Illegal   
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Appendix 2: Drug related harm scheme 
 
 
Image 3. Source: D. Nutt, “Drug harms in the UK”, Lancet, 2010164. 
                                           
164 Supra note 53.  
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Appendix 3: U.S. states that have legalized (medical) cannabis 
State Year adopted Possession Limit 
1. Alaska 1998 28.35 g usable, 6 plants 
2. Arizona 2010 71 g usable, 12 plants 
3. California 1996 226 g usable, 6 mature or 
12 immature plants 
4. Colorado 2000 57 g, 6 plants 
5. Connecticut 2012 71 g usable 
6. Delaware 2011 170 g usable 
7. Hawaii 2000 113 g usable, 7 plants 
8. Illinois 2013 71 g usable within 2 weeks 
9. Maine 1999 71 g usable, 6 plants 
10. Maryland 2014 30 day supply, amount not 
determined 
11. Massachusetts 2012 60 day supply, max 283 g 
12. Michigan 2008 71 g usable, 12 plants 
13. Minnesota 2014 30 day supply, except 
smokable cannabis 
14. Montana 2004 28.35 g usable, 4 plants, 
12 seedlings 
15. Nevada 2000 71 g, 12 plants 
16. New Hampshire 2013 57 g usable within 10 days 
17. New Jersey 2010 57 g usable 
18. New Mexico 2007 170 g usable, 16 plants 
19. New York 2014 30 day supply, except 
smokable cannabis 
20. Oregon 1998 680 g usable, 24 plants 
21. Rhode Island 2006 71 g usable, 12 plants 
22. Vermont 2004 57 g usable, 9 plants 
23. Washington  1998 680 g usable, 15 plants 
24. District of Columbia 2010 57 g dried 
Table 4. Sources see below: 
1. Alaska - Ballot Measure 8, approved in 1998. 
http://medicalmarijuana.procon.org/sourcefiles/alaska-ballot-measure-8.pdf 
2. Arizona - Ballot Proposition 203, approved in 2010. 
http://medicalmarijuana.procon.org/sourcefiles/arizona-proposition-203-medical-
marijuana.pdf. 
3. California - Ballot Proposition 2015, approved in 1996. 
http://medicalmarijuana.procon.org/sourcefiles/california-proposition-215.pdf 
4. Colorado - Ballot Amendment 20, approved in 2000. 
http://medicalmarijuana.procon.org/view.background-resource.php?resourceID=873
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5. Connecticut - HB 5389, approved in 2012. 
http://medicalmarijuana.procon.org/sourcefiles/Connecticut-hb-5389.pdf 
6. Delaware - Senate Bill 17, signed in 2011. 
http://medicalmarijuana.procon.org/sourcefiles/delaware-senate-bill-17-passed.pdf 
7. Hawaii - Senate Bill 862, signed in 2000. 
http://medicalmarijuana.procon.org/sourcefiles/hawaii-senate-bill-862.pdf 
8. Illinois - House Bill 1, signed in 2013. 
http://medicalmarijuana.procon.org/sourcefiles/Illinois-house-bill-1-enrolled.pdf 
9. Maine - Ballot Question 2, approved in 1999. 
http://medicalmarijuana.procon.org/view.background-resource.php?resourceID=875 
10. Maryland - House Bill 881, signed in 2014. 
http://medicalmarijuana.procon.org/sourcefiles/maryland-hb881-enrolled.pdf 
11. Massachusetts - Ballot Question 3, approved in 2012. 
http://medicalmarijuana.procon.org/sourcefiles/MA-ballot-initiative-2012.pdf 
12. Michigan - Proposal 1, approved in 2008. 
http://medicalmarijuana.procon.org/sourcefiles/MichiganProp1.pdf 
13. Minnesota - SF 2470, signed in 2014.  
http://medicalmarijuana.procon.org/sourcefiles/minnesota-sf2470-3rdengrossment.pdf 
14. Montana - Initiative 148, approved in 2004. 
http://medicalmarijuana.procon.org/sourcefiles/I148.pdf 
15. Nevada - Ballot Question 9, approved in 2000. 
http://medicalmarijuana.procon.org/view.background-resource.php?resourceID=877 
16. New Hampshire - House Bill 573, signed in 2013.  
http://medicalmarijuana.procon.org/sourcefiles/new-hampshire-HB573.pdf 
17. New Jersey - Senate Bill 119, approved in 2010.  
http://medicalmarijuana.procon.org/sourcefiles/NJS119.PDF 
18. New Mexico - Senate Bill 523, signed in 2007. 
http://medicalmarijuana.procon.org/sourcefiles/NewMexicoSB523.pdf 
19. New York - Assembly Bill 6357, signed in 2014. 
http://medicalmarijuana.procon.org/sourcefiles/new-york-ab-6357-2013.pdf 
20. Oregon - Ballot Measure 67, approved in 1998.  
http://medicalmarijuana.procon.org/sourcefiles/oregon-ballot-measure-67.pdf 
21. Rhode Island - Senate Bill 0710, approved in 2006. 
http://medicalmarijuana.procon.org/view.background-resource.php?resourceID=880 
22. Vermont - Senate Bill 76, approved in 2007. 
http://medicalmarijuana.procon.org/sourcefiles/S76Vermont.pdf 
23. Washington - Ballot Initiative I-692, approved in 1998. 
http://medicalmarijuana.procon.org/sourcefiles/Chapter69.51ARCW.pdf 
24. District of Columbia - Amendment Act B18-622, signed in 2010. 
http://medicalmarijuana.procon.org/sourcefiles/DCMJLawMay2010.pdf
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Appendix 4:  
Cannabis use in states of Colorado and Washington, youth 
Cannabis use, by age and State, %, annual averages 
    
Use in past 
year 
Use in past 
month 
Perception of 
great risk from 
smoking 
cannabis once 
a month 
First use of 
Cannabis 
  
    
2002-
2003 
2013-
2014 
2002-
2003 
2013-
2014 
2
002-
2003 
2013-
2014 
2002-2003 
2013-
2014 
1
2
-1
7
 y
e
a
r-
o
ld
s
 
Colorado 
1
9.55 
2
0.81 
9.82 1
2.56 
2
8.97 
1
7.04 
7.59 9.13 
Washington 
1
7.64 
1
7.53 
9.11 1
0.06 
2
6.99 
1
6.22 
7.14 6.7 
Total U.S. 
1
5.38 
1
3. 28 
8.03 7
.22 
3
3.66 
2
3.54 
6.57 5.6 
1
8
-2
5
 y
e
a
r-
o
ld
s
 
Colorado 
3
6.57 
4
3.95 
2
1.67 
3
1.24 
1
7.51 
8.39 8.1 10.19 
Washington 
3
6.16 
3
6.5 
2
1.22 
2
4.47 
1
6.3 
8.92 7.11 8.75 
Total U.S. 
2
9.13 
3
1.78 
1
7.17 
1
9.32 
2
4.19 
1
4.22 
6.82 7.68 
Source: 
http://www.samhsa.gov/data/sites/default/files/NSDUHsaeLongTermCHG2014/NSDUHsaeLongTe
rmCHG2014.htm.  
